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ABSTRACT 
 
 
 
Signaling in context: parsing the adhesion-dependence  
of growth factor signaling 
 
February, 2007 
 
 
Niki Galownia, B.S., Case Western Reserve University 
M.S., California Institute of Technology 
Ph.D, California Institute of Technology 
 
 
 
Intracellular signaling induced by adhesion and soluble growth factors is a 
significant contributor to cellular function.  The serine/threonine kinase, extracellular 
signal-regulated kinase (Erk), is a prominent point of signaling crosstalk between 
adhesion and growth factors.  Despite extensive effort, the effect of individual growth 
factors on adhesion-dependent Erk signaling remains unclear due to considerable 
protocol differences and qualitative analyses.  To address these issues, we developed an 
experimental technique to compare systematically the crosstalk between adhesion and 
individual growth factors and a quantitative protocol for measuring the magnitude and 
dynamics of Erk signaling. 
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Using these methods, we demonstrate that: (1) Adhesion to fibronectin 
desensitizes Erk activation for cells stimulated by either PDGF (platelet-derived growth 
factor) or bFGF (basic fibroblast growth factor), but not by EGF (epidermal growth 
factor); (2) EGF, but not PDGF or bFGF, induces adhesion-dependent Erk activation 
enhancement; and (3) for adherent cells, either EGF or PDGF stimulation generates 
transient Erk activation, while bFGF stimulation mediates sustained Erk activation.  This 
data reveal that there are significant differences in the adhesion-dependence of growth 
factor signaling.  The most striking observation was that adhesion desensitizes cells to 
low doses of specific growth factors (PDGF and bFGF).  Studies conducted to uncover 
the underlying mechanism(s) revealed that adhesion-mediated desensitization of Erk 
activation exhibits rapid kinetics and occurs at or above the level of Ras activation, but 
does not involve Sos hyperphosphorylation. 
To further probe the mechanisms responsible for generating different Erk 
signaling dynamics, we constructed a simple coarse-grain model of Erk activation and 
deactivation pathways.  These pathways are represented by four distinct motifs: 
activation, constitutive direct-deactivation, feedback-mediated direct-deactivation, and 
feedback-decoupling.  Our model predicts that transient and sustained Erk signaling 
dynamics require specific combinations of the four signaling motifs.  These predictions 
suggest that differences in the Erk activation motif are most likely responsible for the 
experimentally observed characteristics of adhesion-dependent EGF-mediated Erk 
signaling.  Furthermore, the model indicates either feedback-decoupling deactivation or 
direct-deactivation as the mechanisms responsible for the observed transient-versus-
sustained signaling dynamics induced by different growth factors.     
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Chapter I. Introduction 
 
Cell adhesion to the extracellular matrix (ECM) is critical for multiple cellular 
functions including migration, survival, apoptosis, and proliferation.   In fact, 
carcinogenic cells gain anchorage-independence, retaining the ability to proliferate 
without adhesion to the ECM (Assoian, 1997; Schwartz and Assoian, 2001).  
Additionally, cell adhesion is important in the area of biomaterial development.  
Understanding how adhesion affects cellular function is critical in determining the 
appropriate epitopes required on a biomaterial surface to induce adhesion.  Importantly, 
quantification of growth factor-induced adhesion-dependent signals is a key challenge in 
assessing the quality and effectiveness of both biomaterials and cancer therapies.   
 
To begin to understand cellular adhesion, it is necessary to discuss the proteins 
responsible for cell attachment to the ECM.  Cell adhesion is mediated by heterodimeric 
transmembrane proteins called integrins (Asthagiri et al., 1999; Giancotti and Ruoslahti, 
1999; van der Flier and Sonnenberg, 2001; Vinogradova et al., 2002; Vuori, 1998).  Each 
integrin contains an alpha and beta extracellular domain that combine to form 24 
heterodimers.  It is these heterodimers that determine to which ECM proteins the integrin 
will bind (van der Flier and Sonnenberg, 2001).  The ECM protein fibronectin (FN) has 
been well characterized in mediating cellular adhesion and spreading (Pierschbacher and 
Ruoslahti, 1984).  In fact, the Arg-Gly-Asp (RGD) domain of FN has been termed the 
cell-binding domain due to its presence in several other ECM proteins known to bind to 
cells (Hersel et al., 2003; Pierschbacher and Ruoslahti, 1984; Ruoslahti and 
Pierschbacher, 1987).   Although many integrins can bind FN, the α5β1 integrin is the 
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main FN receptor on most cells.  In addition, binding of α5β1 to FN has been implicated 
as important in supporting mitogen proliferation in endothelial, epithelial, and fibroblast 
cells (Danen and Yamada, 2001)  
 
While integrins themselves do not have any intrinsic catalytic signaling ability, 
integrin binding to ECM proteins induces integrin clustering and subsequent focal 
adhesion formation that affects multiple signaling pathways within cells (Danen and 
Yamada, 2001).  Structural components such as actin fibers and cortical actin filaments 
also associate with focal adhesions; thereby providing a link between integrin-mediated 
signaling and the cytoskeleton (Vuori, 1998).  Ultimately, these complexes initiate 
signaling cascades that lead to cytoskeleton rearrangement and integrin-mediated gene 
transcription (Asthagiri et al., 1999; van der Flier and Sonnenberg, 2001).  Importantly, 
these integrin-mediated signals enforce an adhesion requirement for proliferation in the 
majority of normal cells (Schwartz and Assoian, 2001).   
 
Interestingly, adhesion alone is not sufficient to maintain survival or induce 
proliferation (Assoian, 1997; Asthagiri et al., 2000; Danen et al., 2000; Schneller et al., 
1997; Schwartz and Assoian, 2001; Vuori and Ruoslahti, 1994).   Instead, signaling 
events induced by soluble growth factors are also essential.  It is the combined effect of 
signaling induced by integrin-mediated adhesion and soluble growth factors that is 
necessary for cell viability and proliferation; thus, it is not surprising that both adhesion 
and soluble growth factors affect similar signaling pathways (Assoian, 1997; Danen et 
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al., 2000; Pu and Streuli, 2002; Roovers and Assoian, 2000; Schneller et al., 1997; 
Schwartz and Assoian, 2001; Vuori and Ruoslahti, 1994).   
 
While both integrins and growth factors affect similar signaling pathways, the 
means by which they elicit these signaling events differ.  Unlike integrins, soluble growth 
factors, including epidermal growth factor (EGF), platelet-derived growth factor (PDGF), 
basic fibroblast growth factor (bFGF), and insulin, do not affect the cell structure.  
Instead, they actively induce signaling by directly binding to their growth factor specific 
receptor.  This ligand binding induces the catalytic activity of the transmembrane 
receptor and elicits a signal cascade ultimately affecting numerous cellular functions.  
 
 Because of the physiological importance of adhesion- and growth factor-
mediated cell regulation, significant attention has been given to uncovering the 
underlying signaling mechanisms relating the two.  One prominent point of crosstalk 
between adhesion and growth factors involves the serine/threonine kinase, extracellular 
signal-regulated kinase (Erk).  Although Erk activation is generally viewed as a result of 
activation of the canonical growth factor-mediated mitogen activated protein kinase 
(MAPK) signaling pathway, integrin-mediated signaling ultimately results in the 
enhancement of Erk activation.  While we leave a detailed discussion of the pathways by 
which integrins affect and enhance MAPK signaling to Chapter 4, growth-factor 
mediated activation of the canonical MAPK pathway is presented here.     
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Growth factor-mediated activation of the canonical MAPK pathway begins with 
the binding of a soluble growth factor ligand to its respective receptor.  The ligand 
binding elicits tyrosine autophosphorylation of the receptor (Ford and Pardee, 1999; 
Roovers and Assoian, 2000), which enables growth factor receptor bound protein 2 
(Grb2) to bind to the now activated receptor.  The Grb2-growth factor receptor complex 
then recruits and binds with the guanosine 5’-triphosphate exchange factor, son-of-
sevenless (Sos) (Roovers and Assoian, 2000).  Sos-mediated nucleotide exchange 
activates Ras by converting it to its GTP form, which enables it to bind to and activate 
Raf, initiating activation of the MAPK cascade.  Active Raf kinase binds to and activates 
Mek, which binds to and activates Erk, eventually leading to S-phase entry (Ford and 
Pardee, 1999; Roovers and Assoian, 2000) if also activated by integrin-mediated 
pathways.     
 
In most normal cells, Erk must be activated by both integrins and growth factors 
in order to induce proliferation.  Thus, it is the combined effect of integrin-mediated 
activation pathways and growth factor-induced signaling events that enables active Erk to 
translocate into the nucleus.  Once inside the nucleus, active Erk phosphorylates Elk-1 
and enables cyclin D1 transcription (Aplin et al., 2001; Ford and Pardee, 1999; 
Khokhlatchev et al., 1998; Pu and Streuli, 2002; Roovers and Assoian, 2000).  Cyclin D1 
then forms a complex with cyclin-dependent kinase 4/6 (cdk4/6 ) that is able to 
phosphorylate the tumor-suppressor retinoblastoma protein (Rb) (Assoian, 1997; Ford 
and Pardee, 1999; Pu and Streuli, 2002).  Rb is normally complexed with E2F.  However, 
upon phosphorylation, Rb is released from the E2F complex, enabling the transcription of 
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numerous genes involved in DNA synthesis and ultimately leading to S-phase entry and 
proliferation (Assoian, 1997; Ford and Pardee, 1999; Pu and Streuli, 2002). 
 
The nature of Erk signaling has been intensely studied.  While some studies 
suggest that it is the early phase of growth factor-mediated Erk signaling that is enhanced 
by adhesion (Danen et al., 2000; DeMali et al., 1999; Lin et al., 1997 ), others have 
suggested that it is dynamic changes in Erk activation, and not the early magnitude of the 
signal, that is important (Danen et al., 2000; Jones and Kazlauskas, 2001; Renshaw et al., 
1999; Roovers et al., 1999; Tombes et al., 1998).  Yet others still report no synergism 
between adhesion and soluble growth factors in Erk signaling (Hedin et al., 1997; 
Mettouchi et al., 2001).  These discrepancies are attributable to the use of different cell 
systems, different synchronization methods, different growth factor cocktails, and 
different adhesive contexts (Danen et al., 2000; DeMali et al., 1999; Renshaw et al., 
1997; Roovers et al., 1999).  These discrepancies in experimental protocols make it 
difficult to decipher whether adhesion enhances Erk signaling in response to all of these 
growth factors or whether only a subset of growth factors signal in an adhesion-
dependent manner.  In addition, conclusions regarding differences in dynamic activation 
profiles (either manifesting themselves as a difference in magnitude or as a shift from 
transient to sustained signal) cannot be resolved from the current body of literature.    
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In an effort to answer these questions, we chose to examine quantitatively the 
effect of adhesion and specific growth factors on Erk activation.   We first developed an 
experimental system that enables systematic comparison of the crosstalk between 
adhesion and individual growth factors.  In addition, we developed a quantitative protocol 
for Western blot imaging and analysis to measure both the magnitude and dynamics of 
Erk signaling.  The development the experimental system and quantitative assay are 
discussed in Chapter 2.   
 
  Interestingly, utilization of our experimental protocol reveals a novel aspect of 
adhesion-dependent growth factor signaling.  As described in Chapter 3, we discovered 
that adhesion selectively desensitizes growth factor-mediated activation of Erk.  To help 
guide our search for the molecular mechanism(s) responsible for differential Erk 
activation dynamics by specific growth factors, we developed a simple coarse-grain 
mathematical model, which is described in detail in Chapter 4.  Finally, Chapter 5 
outlines both the significance of our results and how model predictions of key molecular 
mechanisms may be further examined in future work.   
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Chapter II.  Developing an Experimental Platform for Quantifying 
Adhesion-Dependent Signaling 
 
1. Abstract 
 
A prominent point of signaling crosstalk between adhesion and growth factors 
involves the serine/threonine kinase, extracellular signal-regulated kinase (Erk).  
Extensive effort has been invested in understanding adhesion-dependent Erk signaling.  
However, because of the considerable differences in protocols and the qualitative nature 
of past studies, the effect of individual growth factors on adhesion-dependent Erk 
signaling remains unclear.  To address these issues, we developed: (1) an experimental 
system that enables systematic comparison of the crosstalk between adhesion and 
individual growth factors and (2) a quantitative protocol for measuring both the 
magnitude and dynamics of Erk signaling.  The experimental system avoids potentially 
confounding contributions from serum by conducting each step of the protocol in 
completely serum-free medium.  We find that serum augmentation is necessary to 
maintain NIH-3T3 cell viability only when late signaling kinetics are examined.  We 
have identified a 4-5 hour window during which serum supplementation is unnecessary to 
maintain cell viability.  These serum-free conditions, coupled with optimized methods for 
maintaining cells in suspension, should now enable us to directly study the adhesion-
dependence of specific growth factors.  Unique to existing methods used to quantify 
adhesion-dependent Erk activation, we also employ standards in every Western blot to 
confirm the linear range of the assay.  These standards are also used to optimize antibody 
incubation protocols. The development of a rigorous  experimental system and 
quantitative methods for imaging and analysis well equips us to investigate the effect of 
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integrins and individual growth factors on adhesion-mediated signaling, which we 
discuss in subsequent chapters.  
2. Introduction 
 
Cell adhesion generates intracellular signals that affect multiple cellular functions 
including proliferation, survival, and apoptosis (Asthagiri et al., 1999; Giancotti and 
Ruoslahti, 1999; van der Flier and Sonnenberg, 2001; Vinogradova et al., 2002; Vuori, 
1998).   While proliferation of mammalian cells is dependent on a myriad of 
environmental factors, stimulation both by soluble growth factors and by integrin-
mediated adhesion is among the most important.   In fact, loss of adhesion in normal cells 
generally results in complete cell cycle arrest (Assoian, 1997; Schwartz and Assoian, 
2001).  In addition, loss of integrin-mediated cell adhesion initiates apoptosis in 
susceptible cell types such as endothelial human umbilical vein (HUVEC) cells 
(Meredith et al., 1993), gut epithelial cells (Meredith et al., 1993), normal Madin-Darby 
canine kidney (MDCK) epithelial cells (Frisch and Francis, 1994), and spontaneously 
immortalized non-transformed human keratinocyte (HaCat) cells  (Frisch and Francis, 
1994).  Because the majority of normal cells require adhesion to an ECM in order to 
proliferate, it is not surprising that deregulation of adhesion-dependent proliferation often 
contributes to cancer development.  In fact, the formation and spread of tumors is closely 
associated with decreased dependence on adhesion to extracellular matrix proteins 
(Assoian, 1997; Schwartz and Assoian, 2001).   
 
  An important integrin-mediated signaling pathway involves activation of the 
mitogen activated protein kinase (MAPK) pathway, which is also triggered by growth 
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factor stimulation (Danen et al., 2000; Ford and Pardee, 1999; Giancotti and Ruoslahti, 
1999; Pu and Streuli, 2002; Renshaw et al., 1997; Roovers and Assoian, 2000; Roovers et 
al., 1999; Schlaepfer et al., 1994; Schneller et al., 1997; Schwartz and Assoian, 2001; 
Vuori and Ruoslahti, 1994).  Interestingly, Erk activation by either integrins or growth 
factors alone is not sufficient for S-phase entry, and, by extension, proliferation (Assoian, 
1997; Danen et al., 2000; Schneller et al., 1997; Schwartz and Assoian, 2001; Vuori and 
Ruoslahti, 1994).  However, the combined effects of integrins and growth factors have 
been shown to synergistically amplify Erk signaling and ultimately lead to S-phase entry 
and proliferation (Assoian, 1997; Danen et al., 2000; Pu and Streuli, 2002; Roovers and 
Assoian, 2000; Schneller et al., 1997; Schwartz and Assoian, 2001; Vuori and Ruoslahti, 
1994).   
 
While some studies suggest that it is the early magnitude of Erk signaling that 
confers its adhesion-dependence (Danen et al., 2000; DeMali et al., 1999; Lin et al., 
1997), others have suggested that it is the changes in Erk signaling dynamics over 
extended time periods that are actually important (Danen et al., 2000; Jones and 
Kazlauskas, 2001; Renshaw et al., 1999; Roovers et al., 1999; Tombes et al., 1998).  Yet 
others report no synergism between adhesion and soluble growth factors in Erk signaling 
(Asthagiri and Lauffenburger, 2000; Hedin et al., 1997; Mettouchi et al., 2001).  These 
discrepancies may be attributed to the use of different cell systems, different 
synchronization methods, different growth factor cocktails, and different adhesive 
contexts.  For example, while NIH-3T3 cells are prevalent throughout the literature 
(Danen et al., 2000; Renshaw et al., 1997; Roovers et al., 1999), other cell type, including 
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Ph cells and F cells (DeMali et al., 1999) or NIH-3T3 cells expressing transfected 
constructs, are also used (Roovers et al., 1999).  In addition, not all studies serum-starve 
cells before plating (Renshaw et al., 1997), and some include small amounts of serum in 
the starvation medium (DeMali et al., 1999; Renshaw et al., 1997).  Serum is also 
included in the growth factor stimulation medium, with the amount of serum varying 
from as little as 0.4% (Renshaw et al., 1997) to as much as 5% (Roovers et al., 1999).  
Use of multiple growth factors in stimulation medium also occurs (Danen et al., 2000) 
 
Furthermore, not all adhesion studies use defined surfaces, where a single ECM 
protein, such as fibronectin (FN), is exclusively used to mediate cell adhesion.  Instead, 
some allow the cells to adhere to tissue culture dishes coated with ECM proteins from 
serum prior to growth factor stimulation (Renshaw et al., 1997; Roovers et al., 1999).  
The method for maintaining non-adherent cells also varies in the literature; some employ 
poly-L-lysine(PL)-coated surfaces to mediate non-specific attachment via electrostatic 
interactions (DeMali et al., 1999), while others utilize agarose-coated dishes to maintain 
cells in suspension (Danen et al., 2000; Renshaw et al., 1997; Roovers et al., 1999).  The 
time cells are either maintained in suspension or allowed to adhere to FN-coated surfaces 
prior to growth factor stimulation, or the ‘priming time,’ also varies widely in the 
literature.  Some prime cells for substantial amount of time prior to growth factor 
stimulation (Danen et al., 2000; Renshaw et al., 1997), while others choose not to prime 
cells at all (Roovers et al., 1999).    
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Finally, adhesion-mediated Erk signaling is often analyzed only in qualitative 
terms.  In studies that attempt to quantify Erk signaling, densitometry of film-based 
techniques is often used.  As film-based techniques are known to easily saturate, and 
standard curves are not provided with the data, one can never be certain that quantitative 
data obtained via densitometry occurs within the linear dynamic range of the imaging 
protocol.    
 
Because of these discrepancies in experimental protocols, it remains unclear 
whether adhesion-dependent Erk signaling is specific to particular growth factors.   Thus 
we sought first to establish an experimental system to study adhesion-dependent 
signaling, and then to develop quantitative methodologies to accurately measure these 
adhesion-mediated signals. 
 
3. Results and Discussion 
 
3.1     Considerations in developing a protocol to study adhesion-mediated signaling 
 
Adhesion and growth factor synergy has been investigated by comparing 
differences in signaling between adherent and non-adherent cells stimulated by growth 
factors.  However, due to the many the differences in both the experimental systems and 
the protocols employed in previous adhesion-dependent studies, it remains unclear 
whether adhesion-dependent Erk signaling is specific to particular growth factors.   Thus, 
we are left with many possibilities for which cell type to examine, how to lift cells from 
the dish, which kind of adhesive and non-adhesive surface to utilize, whether starvation 
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medium is necessary to quiesce residual Erk signaling in the cells, and whether 
supplementing starvation and/or stimulation media with serum is required to maintain 
high cell viability.  Because our goal is to develop an adhesion protocol that enables 
direct comparison of the effects of adhesion and a single growth factor on Erk signaling, 
each protocol development decision we make will be with this objective in mind.  
 
 In order to fulfill our goal of developing an experimental system to enable direct 
comparison of three individual growth factors (EGF, PDGF, or bFGF) on adhesion-
dependent Erk activation, it is essential that each experiment be conducted using the same 
experimental system.  Each experiment must utilize the same cell type, a consistent 
method to lift cells, the same plating method, identical starvation medium formulations, 
equivalent stimulation medium formulations prior to growth factor addition, equivalent 
plating methods for adherent and non-adherent cells, and identical analysis and imaging 
techniques.  Thus, we seek to develop a consistent protocol to acquire data that will begin 
to provide a systematic comparison of the crosstalk between adhesion and individual 
growth factors.   
 
Development of this experimental protocol required careful consideration of the 
effect that each choice we made would have on our experimental system.  For example, 
during determination of the appropriate cell detachment technique, we had to consider 
how each option would affect the integrity of the integrins.  Integrin damage is known to 
occur via protease exposure.  Thus, we were careful to add a protease inhibitor to cells 
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immediately after detachment when a protease-containing cell detachment method was 
used.     
 
The possible formation of cell aggregates following detachment was another 
important consideration.  Cell aggregation must be prevented because such cell-cell 
contact can initiate cadherin-mediated signaling that convolutes proper data 
interpretation.  Although some cell-cell contact during re-suspension is likely, cells can 
be quickly separated via trituration to limit the effects of cadherin-mediated signaling.  
However, excessive trituration can negatively affect cell viability, and thus should be 
avoided.  In cases where the cell aggregates cannot be separated, the cell suspension must 
not be used for experiments due to probable cadherin-mediated signaling. 
 
The presence of residual adhesion-mediated signaling resulting from cell 
attachment to matrix proteins in serum is an equally important consideration.  Cells are 
cultured on uncoated tissue culture dishes in serum-containing growth media.  To return 
Erk signaling to basal levels and prevent residual Erk activation from confounding 
interpretation of adhesion- and/or growth factor-induced signaling, serum-starvation prior 
to re-plating of cells for experiments was investigated.  As quiescing residual signals by 
deprivation of both serum and integrin engagement is known to induce apoptosis   
(Levine and Klionsky, 2004; Reddig and Juliano, 2005), maintaining cell viability is also 
a concern.  Clearly, from a data-analysis standpoint, excluding serum from starvation and 
stimulation media is most desirable.  However, the cells must remain viable to obtain 
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valid results.  Therefore, the balance of serum use and cell viability was closely 
evaluated.    
 
In addressing these considerations, we developed an experimental protocol that 
limits the use of serum to ensure that signaling responses can be clearly attributed to 
adhesion and a specific growth factor.  Moreover, conditions that minimize cell clustering 
and quiesce pre-stimulatory Erk signaling were identified.  Together, the developed 
experimental protocol provides a systematic platform for parsing the crosstalk between 
cell adhesion- and growth factor-mediated signaling.  
 
3.2     Maintaining high cell viability while eliminating cell aggregation  
 
Our studies focused on the NIH-3T3 cell line, since it has served as the preferred 
line for adhesion-mediated signaling studies (Danen et al., 2000; Renshaw et al., 1997; 
Roovers et al., 1999).  Maintaining high NIH-3T3 cell viability is a concern through each 
phase of the protocol, including the step where cells are detached from the culture dish.  
Multiple factors can affect cell viability during detachment including prolonged exposure 
to proteases and removal of cells via mechanical shearing.  In addition to cell viability 
issues, the formation of cell aggregates following cell detachment can also readily occur. 
 
A variety of solutions can be used for cell detachment, with some containing only 
chelating agents (such as EDTA) and others containing a combination of both chelating 
agents and proteases (such as trypsin diluted in EDTA).  However, chelating agents alone 
do not always result in complete detachment.   Thus, the presence of a protease can be 
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required to further detach the cell from the dish.  However, as proteases are known to 
damage cell surface receptors, care must be taken to avoid prolonged protease exposure.  
Thus, the lowest concentration of protease necessary to induce efficient detachment 
should be used to mitigate potential cell-receptor damage.   
 
We investigated six different detachment agents: 5 mM EDTA alone, 0.48 mM 
EDTA alone, 0.01% trypsin diluted in 5 mM EDTA, 0.01% trypsin diluted in 0.48 mM 
EDTA, 0.05% trypsin diluted in 0.48 mM EDTA, and 0.25% trypsin diluted in 1 mM 
EDTA.   Although 0.48 mM EDTA and 5mM EDTA elicit the least amount of cell- 
receptor damage due to the absence of a protease, neither method was able to induce cell 
detachment even after exposure of up to 45 min.  As a result, substantial mechanical 
shearing from the force of the EDTA solution being washed over the dish during cell 
collection was required to dislodge cells from the dish, and use of both concentrations of 
EDTA alone resulted in approximately 50% cell viability as assayed via trypan blue 
staining (data not shown).   
 
While adding 0.01% trypsin to either 0.48 mM EDTA or 5 mM EDTA induced 
cell detachment within 7 min and enabled complete detachment of cells from the dish, 
significant cell aggregation resulted upon re-suspension.  Only via vigorous trituration—
which resulted in 20-40% viability, as assayed via trypan blue staining—could single-cell 
suspensions be obtained (data not shown).   Although cell viability improved 
significantly when less trituration was employed, a single cell suspension could not be 
obtained.  Thus detachment methods with only 0.01% trypsin were eliminated, due to 
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either probable cadherin-mediated signaling from cell aggregates that remained after mild 
trituration, or due to poor cell viability that occurred when vigorous trituration was used 
to separate cell aggregates.        
 
When the trypsin concentration was increased to 0.05% trypsin in 0.48 mM 
EDTA or 0.25% trypsin in 1 mM EDTA, detachment again occurred within 7 min.  
Single-cell suspensions were obtained after mild trituration and high cell viability was 
maintained, establishing both as potential detachment agents.  However, as trypsin is 
known to elicit some degree of integrin and receptor damage, the solution with the lower 
concentration of trypsin, 0.05% trypsin in 0.48 mM EDTA, was selected as optimal.  To 
further minimize cell-receptor damage, we employed soybean trypsin inhibitor 
immediately following cell detachment.  Thus, although protease use cannot be avoided, 
as its presence is required for both high cell viability and elimination of cell aggregate 
formation upon re-suspension, we efficiently mitigate its potential negative effects via 
low trypsin concentration, short contact time, and the addition of an inhibitor 
immediately following detachment.   
 
Cell viability and aggregation issues can also occur as a result of the 
methodologies used for either facilitating or preventing cell adhesion.  While undefined 
surfaces coated with ECM proteins found in serum can be used to facilitate adhesion 
(Renshaw et al., 1997; Roovers et al., 1999), it is difficult to ascertain the contribution of 
specific integrins on signal activation.  Thus, we used a defined surface to facilitate 
adhesion; specifically, we selected fibronectin, as it is the most common ECM used in 
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defined surface studies (DeMali et al., 1999; Lin et al., 1997; Renshaw et al., 1997; 
Roovers et al., 1999).   
 
To complement the experimental condition where cells are adhered to a 
fibronectin-coated substratum, a condition where cells are cultured in an adhesion-free 
environment was also developed.  A survey of the literature revealed that methods for 
preventing integrin-mediated attachment vary widely.  While some studies use poly-L-
lysine (PL)-coated surfaces to prevent adhesion-mediated attachment due to integrin 
binding (DeMali et al., 1999), others use agarose-coated tissue culture dishes to maintain 
cells in suspension (Danen et al., 2000; Renshaw et al., 1997; Roovers et al., 1999).   We 
also explored poly-HEMA (PH)-coated surfaces as a potential suspension method.  
Although not traditionally used in integrin and growth factor signaling studies, PH is the 
most widely utilized approach for holding cells in suspension during suspension-induced 
anoikis studies (Folkman and Moscona, 1978b; Frisch and Francis, 1994; Kawada et al., 
1997; Lebowitz et al., 1997; Reginato et al., 2003).  The mechanism by which adhesion is 
inhibited via each of these methods is further discussed in the following paragraphs.   
 
PL enables cell attachment to the culture dish via an electrostatic interaction 
between the cell membrane and the tissue culture dish surface.  Thus, although no 
integrin engagement should occur when cell are adhered to PL, cells do experience an 
electrostatic force that holds them to PL-coated surface.  We eliminated PL as the optimal 
method for non-adherent cells because the cells are subjected to an electrostatic force 
absent in the adherent condition.   
  
II-12
 
Agarose-coated dishes inhibit cell attachment by presenting a surface that cells 
supposedly cannot adhere to.  However, preliminary experiments using agarose-coated 
dishes that were gently rocked to avoid the settling of cells proved this method 
unacceptable for use as substantial cell aggregation resulted (Figure II-1A).  Moreover, 
cells embedded into the agarose surface over time, resulting in poor cell recovery.  
Additionally, actual cell adhesion to the agarose coated surface also occurred (Figure 
II-1A).   Clearly, agarose is not an ideal surface for the suspension protocol.   
 
 
 
A 
 
 
 
 
B  
 
 
Figure II-1: Suspension on poly-HEMA-coated dishes  
NIH-3T3 cells were starved for 20 h, allowed to adhere for 2.5 h, and stimulated 
with 0.81 mM of PDGF.  (A) Severe cell aggregation occurs on agarose-coated 
dishes  Cells plated on 60 mm agarose dishes containing 3 mL total medium volume 
experience substantial clumping.  Some adhesion to the agarose-coated surface is 
also observed.   (B) PH-coated dishes eliminate cell clumping Cells plated on 100 
mm PH-coated dishes containing 11 mL total medium volume subjected to gentle 
rocking displays no cell aggregation.   
 
 
  
II-13
As mentioned previously, PH is the most commonly used substrate for holding 
cells in suspension during anoikis studies.  When alcoholic solutions of PH are allowed to 
evaporate onto a plastic tissue culture dish, a thin, hard, non-ionic sterile film of optically 
clear polymer remains tightly bonded to the plastic surface.  This non-ionic film inhibits 
cell attachment by preventing matrix deposition and subsequent cell adhesion to the PH-
coated surface (Folkman and Moscona, 1978a; Frisch and Francis, 1994).  Although 
during initial testing, cells plated on PH-coated dishes settled to the bottom of the dishes 
and cell aggregates formed, increasing the total medium volume from 3 mL in a 60 mm 
dish to 11 mL in a 100 mm dish and subjecting the dishes to gentle rocking eliminated 
these problems (Figure II-1B).   
 
3.3     Maintaining high cell viability while minimizing serum supplementation    
 
Maintaining high cell viability has been an important issue during the 
development of our experimental protocol.  Although minimizing serum use is important 
in determining the contribution of individual growth factors on signal activation, the 
decision of whether or not to use serum in the starvation and/or stimulation media 
completely relies upon whether or not serum is necessary to sustain high cell viability.   
 
NIH-3T3 cells undergo apoptosis as a result of prolonged exposure to completely 
serum-free medium (data not shown).   As mentioned previously, serum augmentation of 
the starvation and stimulation media improves cell viability, but its presence also 
prevents ascertainment of the effect of individual growth factors on Erk activation due to 
the presence of the many signal-inducing proteins present in serum.  Moreover, 
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restoration of basal signal activation levels is unattainable in the presence of large 
amounts of serum.  For these reasons, exclusion of serum from the experimental protocol 
is ideal.   
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Figure II-2: Determination of optimal starvation medium.   
NIH-3T3 cells were starved for 24 h (empty) or 48 h (filled) in completely serum-free 
medium (serum-free) or in completely serum-free medium supplemented with 
increasing amounts of serum (0.1% serum, 0.5% serum, 1% serum, or 5% serum).   All 
proteins have been normalized to their respective total Erk equal loading control. (A) 
Measure of apoptosis resulting from starvation  Normalized cleaved caspase3 
induction after 24 h (white bars) or 48 h (black bars) of starvation.  (B) Ability of 
starvation media to quiesce Erk Activation  Normalized Erk activation after 24 h 
(white bars) or 48 h (black bars) of starvation. 
 
 
To determine if the presence of serum was necessary for high cell viability during 
quiescing of the cells, the presence of cleaved caspase 3, a known marker of apoptosis, 
was assayed for cells exposed to starvation medium containing increasing concentrations 
of serum.  Cells were starved for 24 h and 48 h in completely serum-free medium or in 
completely serum-free medium supplemented by 0.1%, 0.5%, 1%, or 5% serum.  After 
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24 h, there was little difference in survival of cells starved in completely serum-free 
medium as compared to cells starved in serum-free media supplemented with either 0.1% 
or 0.5% serum (Figure II-2A).  Supplementation by 1% and 5% serum reduced cleaved 
caspase3 to nearly basal levels.  Starvation in a completely serum-free medium for 48 h 
was not an option, as NIH-3T3 cells are unable to survive serum deprivation for such an 
extended amount of time.  After 48 h, the majority of the cells had detached from the dish 
(observations) and a significant portion of the remaining cells on the dish were 
undergoing apoptosis.  Interestingly, very little difference in cell survival was observed 
between 24 h of starvation verses 48 h of starvation for 0.1%, 0.5%, 1%, and 5% serum-
supplemented serum-free media (Figure II-2A).     
 
The optimal starvation condition must minimize apoptosis and return Erk 
signaling to basal levels.  Thus, we also examined the ability of each starvation condition 
to quiesce Erk signaling.   Recall that quiescing cells in a completely serum-free medium 
to return adhesion signals to basal levels is ideal, as it enables interpretation of individual 
growth factors without the presence of serum to convolute the results.   Although 
starvation in completely serum-free medium after 24 h quiesced Erk signaling to basal 
(near zero) signal levels (Figure II-2B), the presence of small amounts of cleaved 
caspase3 (Figure II-2A) indicate that a small fraction of cells are undergoing apoptosis.  
Cells starved for 48 h in medium supplemented with either 1% or 5% serum were also 
able to quiesce Erk activation back to basal (near zero) signal levels (Figure II-2B) and 
these were the most effective starvation conditions in minimizing the induction of 
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cleaved caspase 3 (Figure II-2A).   However, the presence of such large amounts of 
serum in the starvation medium convolutes interpretation of the data.   
 
As we suspected, the decision of whether or not to augment the medium with 
serum was a balance between quiescing Erk signaling and maintaining high cell survival.  
While the two starvation media with the highest levels of serum are optimal for viability 
(Figure II-2A), they are the worst conditions from a data-interpretation perspective.  
Likewise, while elimination of serum is the best choice for data interpretation, completely 
serum-free medium induces the highest levels of apoptosis.  Thus, no acceptable 
combination of serum and viability could be found for starvation times of 24 h or 48 h. 
 
We hypothesized that by reducing the starvation time of the completely serum-
free condition, we might find an optimal starvation time where low caspase3 induction 
and effective quiescing of basal signaling resulted from the completely serum-free 
medium condition.  We found that when the starvation time is reduced to 20 hours, 
caspase 3 induction remains low, and both Erk and Akt signaling are quiesced (data not 
shown).  Thus, starvation in completely serum-free medium was selected as the optimal 
choice for quiescing basal signaling in the cell, with experimental starvation times not to 
exceed 20 h. 
 
The compromise between cell viability and clear data interpretation also arises in 
the stimulation medium formation.  The duration of adhesion/suspension time prior to 
growth factor stimulation, or the priming time, is a variable of interest in our 
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experiments.  Thus, we had to determine how long cells could be deprived of growth 
factor stimulation before cell viability becomes an issue, with and without serum 
augmentation. 
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Figure II-3: Induction of cell apoptosis as a function of time in suspension   
NIH-3T3 cells were starved for 20 h in completely serum-free medium, plated on 
FN-coated dishes (adherent cells, black bars) or maintained in suspension via PH-
coated dishes (suspended cells, white bars) for increasing amounts of time.  The 
unstimulated cells were assayed for the presence of cleaved caspase 3 at different 
priming times, and cleaved caspase 3 normalized to its total Erk equal loading 
control is shown.  “X” denotes cells prior to plating (that have been starved for 20 
h).  
 
Cells starved in completely serum-free medium for 20 h, were plated on either 
FN- or PH-coated surfaces for various lengths of time to assay cell viability as a function 
of priming time (Figure II-3).  We find that cleaved caspase 3 induction remains low both 
prior to plating and after priming times for 1.25 h on either FN- or PH-coated surfaces.  
By 2.5 h, caspase 3 induction has increased slightly and by 4 h caspase 3 induction is 
significant, indicating that considerable apoptosis has occurred.  This data reveals that 
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cells can be serum-starved for 20 h and primed for up to 2.5 h without serum 
augmentation.  
 
To establish whether or not serum supplementation of the stimulation medium 
was necessary to sustain high cell viability, the presence of cleaved caspase 3 was 
assayed after cells were starved for 20 h and primed for 2.5 h in completely serum-free 
media, as these are the harshest starvation and priming times conditions found to support 
high cell viability.   Caspase 3 induction over a period of two hours after stimulation by 
EGF, bFGF, or PDGF remained either at or below basal signal induction (data not 
shown).  Thus, serum supplementation of the stimulation medium is not required to study 
Erk signaling kinetics for priming times up to 2.5 hours and for stimulation times up to 2 
hours (data not shown).       
 
Consequently, if the effects of adhesion-dependent signaling for priming times 
longer than 2.5 hours or if proliferative studies requiring the negative control of 
unstimulated cells are to be studied, serum supplementation of both the starvation and 
stimulation media are necessary to enhance cell viability.  In accordance with these 
findings, cell cycle progression studies supplement the starvation and stimulation media 
with serum (Renshaw et al., 1997; Roovers et al., 1999).  However, for the purposes of 
our investigation, which investigates early Erk signaling kinetics, serum supplementation 
is not necessary.   
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3.4     Summary of optimized protocol 
 
Employing this optimized protocol (Figure II-4), adhesion and spreading were 
excellent (Figure II-5A) as compared to cell adhesion and cell spreading from cells  
 
 
 
 
Figure II-4: Optimized adhesion protocol   
Adhesive signals in subconfluent NIH-3T3 cells are quiesced by starvation for 20 h 
using completely serum-free medium.  Cells are detached via 0.05% trypsin in 0.48 
mM EDTA and re-suspended to a concentration of 5*105 cells/mL.   5*105 cells are 
plated on either FN- or PH- coated dishes.  After acclimating to their new 
environment for a prescribed amount of time, cells are stimulated by a single growth 
factor and lysed at the appropriate time.    
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subjected to a non-optimal protocol (Figure II-5B).  Cells from the non-optimal 
experimental protocol completely failed to adhere and spread, while cells from the 
optimal protocol adhered and spread with a morphology consistent with normal growth. 
 
A 
 
 
 
 
B 
 
 
 
Figure II-5: Adherent NIH-3T3 cells using different adhesion protocols 
NIH-3T3 cells were starved and allowed to adhere for 2.5 h before growth factor 
stimulation. (A) Adherent cells starved for 20 h and treated using the optimized 
protocol.  (B) Adherent cells starved for 24 h and treated using sub-optimal 
DMEM (see Materials & Methods). 
 
 
3.5     Developing a quantitative methodology for measuring Erk signaling 
 
The next set of tools needed were analysis techniques to facilitate measurement of 
the lysates generated in our optimized experimental protocol.  To quantify the extent to 
which different growth factors induce adhesion-dependent Erk signaling, we developed a 
systematic, quantitative, Western blotting protocol.  The methodology is based on digital 
imaging using a cooled CCD camera that has a theoretically wider linear dynamic range 
than standard film-based imaging (Budowle et al., 2001; Martin and Bronstein, 1994).  
However, even when signals are within the detection limit of the imaging system, data 
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points do not always conform to the expected linear trend (Figure II-6).  We expect that 
factors such as antigen saturation may contribute to the observed non-linearity.  
 
 
 
 
 
 
Figure II-6: Blot saturation occurs even when operating within the imaging 
system detection limit   
Although signal strength increases with increasing image integration time, blot 
saturation exists for all three integration times.  Thus, blot saturation cannot be 
eliminated by changing the integration time. 
 
To address these sources of non-linearity that may be specific to each blot, we 
developed a quantitative Western blotting protocol that employs standard samples to 
establish the linear dynamic range of each blot.  The standards are a set of dilutions of a 
positive control lysate as illustrated for an anti-Erk Western blot in Figure II-7A.  The 
band intensities from the standard lanes are quantified, and the working linear range is 
established empirically for each blot (Figure II-7C).   Band intensities from the lanes 
loaded with lysates-of-interest are then confirmed to fall within the linear dynamic range 
(Figure II-7C); any band intensities that fall outside the linear dynamic range are 
discarded.  The sole exceptions to this requirement are samples whose basal signal cannot 
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Figure II-7: Quantification of Western blotting Images  
Immunoblot obtained using cooled CCD camera are shown in (A) for ErkT and (B) for 
ppErk.  Lanes 1-4 in each blot represents cells held in suspension for 2.5 hr, prior to 
stimulation for 12 min by one of four different growth factors.   Lanes 5-8 represent cells 
allowed to adhere to FN for 2.5 hr prior to stimulation for 12 min by one of four growth 
factors.  Lanes 9-13 represent standards employed in each blot to ensure that each unknown 
sample is within the linear dynamic range of the blot and that blot saturation has not 
occurred.  Each of the unknown samples (lanes 1-8) and the ErkT standards (lanes 9-13) are 
quantified.  (C) Quantification of ErkT signal for cells held in suspension on PH (open 
circles), cells adhered to FN (solid squares) and for each of the employed ErkT standards 
(asterisks).  (D) Quantification of ppErk for cells maintained in suspension via PH (open 
circles), cells adhered to FN (closed squares), and for each of the employed pp-Erk standards 
(asterisks). (E) Graph represents pp-Erk activation profile (shown in D) normalized to the 
total Erk equal loading control (shown in C).  Because each signal is normalized by the total 
protein loaded, this method ensures the most rigorous means of comparing each growth 
factor’s ability to activate Erk.  
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be distinguished from background noise; typical examples are the initial time-point 
following serum-starvation, or time-points measured after a signal has returned to basal.  
This approach ensures that the measurements of Erk expression levels lie within the 
linear dynamic range of each Western blot.  A similar approach is applied to quantify 
phospho-Erk (ppErk) (Shown in Figure II-7B and Figure II-7D) and phospho-Akt (pAkt) 
(data not shown).  The band intensity associated with a phospho-protein (e.g., ppErk, 
Figure II-7D) is normalized to the band intensity of an equal-loading control, such as 
total Erk (ErkT, Figure II-7C), to adjust for unequal loading, as shown in Figure II-7E.   
 
We note that the same standards are not used in every blot.  Rather, dilutions of 
positive control lysates are used as standards.  This approach ensures that for a particular 
blot, the band intensities of the standards will encompass nearly the entire linear range of 
the blot.  Such an approach increases likelihood that the band intensities of the lysates-of-
interest will fall within the linear range.  
  
To ensure that data collected from two distinct blots can be compared to each 
another, we include a common reference point in each blot.   This reference is a sample 
generated under the same stimulation conditions.  The data (Figure II-7E) is then always 
analyzed and reported relative to this reference point, which in this case was chosen to be 
the PH 12 min time-point stimulated with 800 mM PDGF.  The new graph resulting from 
normalization by the reference point is shown in Figure II-8A.  Including such a 
reference enables comparison of repeated experiments, as shown in Figure II-8B.    Note 
that the normalized signals (Figure II-8A) can only be compared with data that has been 
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normalized by an identical reference point.  Thus the results of Figure II-8A can only be 
directly compared to another graph that has also been normalized by the PH 12 min time-
point stimulated by 800 mM PDGF.  Graphs without identical normalization time-points 
cannot be directly compared. 
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Figure II-8: Normalizing and combining data from different trials   
(A)  Each data point in Figure II-7E is re-normalized to the 12 min time-point for 
suspended cells stimulated via 800 mM PDGF so that experiments from different 
trials can be compared to each other.  (B) An example of how several sets of data are 
normalized to the same condition (in this case, 800 mM PDGF for suspended cells) 
so that experiments from several different trials can be averaged together and error 
bars computed.  
 
Note, however, that ratio of any two time-points in Figure II-8A can be compared 
to the ratio of those same time-points (provided that these two time-points are from the 
same second graph).  For example, we can compare the ratio of the 12 min FN time-point 
stimulated by EGF to the 12 min PH time-point stimulated by EGF in Figure II-8A to the 
ratio of the 12 min FN time-point stimulated by EGF to the 12 min PH time-point 
stimulated by EGF in any other figure; if our data is consistent, we would find these two 
ratios to be identical.  However, we are not able to directly compare any two equivalent 
time-points; for example, we cannot directly compare the 12 min FN time-point 
stimulated by EGF in Figure II-8A to the same time-point (12 min FN time-point 
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stimulated by EGF) in another figure unless both graphs have been normalized to the 
identical time-points (for example, 12 min PH time-point stimulated by 800mM PDGF) 
as described in the previously.   
 
In order for quantitative data to correlate directly to a difference in the imaged 
signals, the data must fall within the linear detection range of both the blot/antibodies of 
interest and the cooled CCD camera itself.  If data taken falls outside of the linear 
measurement range of either, a direct correlation between two protein band images and 
their relative signal strengths cannot be made.  Thus, we must ensure that every blot 
imaged falls within both the linear dynamic range of the cooled CCD camera and the 
linear dynamic range of the antibody and individual blot.    
 
Fortunately, losing data due to the occurrence of machine saturation can be 
readily avoided by ensuring that the feature that indicates when the camera pixel 
detection saturation has occurred is turned on prior to imaging the blot.  This feature 
highlights bands where image saturation occurs; if saturation has occurred in any of the 
samples due to image acquisition over too long of a time period, a new image integrated 
for a shortened length of time can easily be acquired.  It is because saturation occurring 
due to blot/antibody imaging cannot be eliminated during the imaging process that we 
invested extensive time into optimization of each antibody.  By ensuring that the optimal 
lysate amount is loaded into every blot, and optimal antibody incubation times and 
incubation concentrations are employed during our Western blotting protocol, we 
mitigate the number of blots that must be rerun due to blot/antibody saturation.  In 
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addition, we employ standards in every blot to provide a metric for detection of blot 
saturation after imaging; such a rigorous technique facilitates early detection of blot 
saturation so that all data falling outside the linear range can be discarded and rerun using 
smaller amounts of lysate. 
3.6     Extending quantitative approach to other intracellular signals 
 
In addition to measuring Erk signaling, protocols were developed for quantitative 
measurement of other signaling proteins in cell lysates.  The quantitative imaging 
techniques utilized in this project directly affect our methodology for optimizing antibody 
incubation protocols.  To ensure that a direct correlation exists between the observed 
protein band image and the actual amount of protein present in our sample, we must 
ensure that each lysate of interest falls within the linear dynamic range of the antibody.  
In order to determine the linear dynamic range of each antibody, several identical 
standard curves are incubated in different concentrations of the same antibody of interest, 
and the antibody concentration yielding the best linear dynamic range with a good signal-
to-noise ratio is chosen as optimal.      
 
For example, Figure II-9 below illustrates the process of optimizing antibody 
usage for the detection of phospho-Mek298 (p-Mek298).   We were originally interested in 
developing an optimized protocol to image phospho-Mek298 because of reports that 
phosphorylation of the serine-298 residue of Mek1 by adhesion is necessary for efficient 
growth factor-mediated activation of Mek, and subsequent activation of Erk (Slack-Davis 
et al., 2003).  In order to optimize phospho-Mek298 for imaging, we analyzed standard 
curves at several different primary antibody incubation concentrations, and quantitatively 
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determined that a dilution of 1:5000 yielded the largest linear range between the 
measured signal strength and the lysate amount (Figure II-9).  Moreover, a lysate amount 
of 7.5 μg was determined as the optimal amount to load for p-Mek298 imaging, as this 
value yielded both a high signal-to-noise ratio, and allowed for both higher and lower 
signal measurements to fall within the linear dynamic range of the antibody.  A similar 
procedure was followed for each of the other antibodies of interest: pp-Erk, Erk, p-Akt, 
Sos, cyclin D1, and caspase 3. 
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Figure II-9: Quantitative determination of optimal primary antibody conditions 
Four standard curve were subjected to different primary antibody dilutions of 1:1000 
(solid circles), 1:5000 (Solid triangles), 1:10000 (open squares), and 1:20000 (solid 
diamonds).   
 
Antibody incubation times were varied to yield optimal imaging conditions.  
Although the antibody incubation protocol for film exposure indicates that primary 
antibody incubations can be run for 1 h at room temperature or overnight at 4 ºC with 
equivalent results, these two conditions yielded distinctly different images when a cooled 
CCD camera was used to image and analyze blots.  Several combinations of primary and 
secondary antibody incubation times were tested to optimize the obtained signal to noise 
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ratio for each antibody run at optimal dilution.  As two optimal antibody incubation time 
protocols exist for film-based techniques, one which optimized for short incubation times 
and one optimized for long incubation times, we wanted to develop similar optimal 
incubation time protocols for our quantitative Western blotting imaging protocol.   The 
results from our optimization of antibody incubation times are depicted in Table II-1 and 
the experimental details can be found in the material and methods section of this text.   
 
 
Company Antibody Animal Cat # μg Primary Antibodies               substrate 
Biosource pMek298 Rabbit 44-460 7.5 
1:5000 ON @ 4 ºC in 3% 
milk/TBST or 1.25h RT, 5-10 h 4 
ºC  
Pico 
Cell 
Signaling  ppErk Rabbit 9101 1.25 
1:20000 1h @ RT in 1% 
BSA/TBST or 1.25h RT, 5-10 h 4 
ºC 
Pico 
Santa Cruz  Erk2 Rabbit sc 154 1.25 
1:10000 1h @ RT in 1% 
BSA/TBST or 1.25h RT, 5-10 h 4 
ºC 
Pico 
Cell 
Signaling  pAkt Rabbit 9271 2.5 
1:1000 1h @ RT in 1% BSA/TBST 
or 1.25h RT, 5-10 h 4 ºC 
Pico 
NeoMarkers cyclin D1 Rabbit RM-9104 10 
1:5000 ON @ 4 ºC in 1% 
BSA/TBST or 1.25h RT, 5-10 h 4 
ºC  
Pico 
Cell 
Signaling  caspase3 Rabbit 9661 15 
 1:500 ON @ 4 ºC in 1% 
BSA/TSBT or 1.25h RT, 5-10 h 4 
ºC 
Pico 
Santa Cruz  Sos1 Rabbit SC-256 10 
1:1000 ON @ 4 ºC in 3% 
milk\/TBST or 1.25h RT, 5-10 h 4 
ºC  
Pico 
Table II-1: Optimized antibody conditions 
The blocking buffer (1% BSA in TBST or 3% milk in TBST) is identical to that used for 
primary antibody incubations.  Blocking is done either at room temperature (for 1h – 4h) 
or overnight at 4 ºC (for up to 24 h).  Secondary antibodies are diluted 1:20000 in 3% 
milk/TBST and are incubated for either 1.5 h at room temperature or 1.25 h at room 
temperature and 5-8 h at 4 ºC.    
 
4. Materials and Methods 
 
4.1     Cell maintenance  
NIH-3T3 fibroblasts (ATTC) were cultured and maintained in 89% DMEM 
(Gibco 11965-118), 10% DCS + Fe (Gibco 10371-029), and 1% PenStrep (Gibco 15070-
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063).  Cells were maintained under subconfluent conditions to avoid transformation, as 
suggested by the commercial provider (ATCC).  Liquid DMEM (Gibco) was used in all 
cell culture, since powdered medium yielded sub-optimal performance, both in terms of 
cell viability and cell adhesiveness.  After approximately 48 h of growth (when cells 
achieved 70-80% confluence) 1 mL of 0.25% trypsin/1mM EDTA (Gibco 25200-072) 
was added to subconfluent cells and cells were allowed to incubate at 37 ºC under 5% 
CO2 for 3 min.  Cells were triturated to inhibit clumping, and added to a 15 mL conical 
tube containing 1 mL culture media.  Cells were again triturated to inhibit clumping, and 
were plated at a ratio of 1:5.  Prior to passing, the surface of each dish was scanned twice 
to ensure that there were no confluent areas on the dish as NIH-3T3 are known to 
transform if grown to too high a confluence.   
 
4.2     Protein-coating surfaces 
 
Fibronectin (FN) (Sigma F0895) was diluted in Dulbecco’s phosphate buffered 
saline (dPBS) (Sigma D5652) to a concentration of 5 ug/mL.  2 mL were added to each 
60 mm Corning plastic tissue culture dish and the cells were incubated overnight at 4 ºC 
on a rocker.  The dishes were then washed twice with cold dPBS and blocked with 
1mg/mL filter sterilized, heat-inactivated, Bovine serum albumin (BSA A7906) diluted in 
dPBS for 1 h at 37 ºC under 5% CO2.   The dishes were washed twice with warm dPBS 
immediately before plating adherent cells.   
 
PH (Sigma P3932) was dissolved in 70% biological grade ethanol (Sigma E7148) 
to a concentration of 6 mg/mL, and 5 mL was added to each 100 mm Corning plastic 
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tissue culture dish.  The dishes were left uncovered, overnight, at room temperature, in 
the tissue culture hood, with the UV light off.  The hood must remain slightly open to 
allow some air flow to occur or the ethanol will not evaporate and the PH polymer layer 
will not form.  PH-coated dishes were then washed twice with warm dPBS prior to 
plating non-adherent cells.  
4.3     Cell adhesion experiments  
 
NIH-3T3 cells were plated at a density of 1:5 in culture media, grown for 
approximately 48 hours, and subconfluent dishes were starved in completely serum-free 
medium (99 % DMEM (Gibco 11965-118), 1% PenStrep (Gibco 15070-063), 1mg/mL 
BSA (Sigma A7906)) for 20 h to quiesce adhesion-mediated signaling to basal levels.  
Serum-starved cells were detached by adding 1mL 0.05% Trypsin in 0.48 EDTA (Gibco 
25300-062) per dish, and allowed to incubate at 37 ºC under 5% CO2 for 7 min.   Cells 
were collected and added to a tube containing an equal volume of 1mg/mL Soybean 
Trypsin Inhibitor (Sigma 93619) in serum-free medium.  Cells were centrifuged at 214.6 
RCF for 3 min and washed twice with 3 mL serum-free medium, being careful not to 
agitate the cells.  Cells were re-suspended in serum-free medium to a concentration of 5 x 
105 cells/mL, and were either plated onto FN-coated 60 mm dishes containing 1 mL 
serum-free medium or 100mm PH-coated dishes containing 9 mL serum-free medium.  
Cells were incubated at 37 ºC under 5% CO2 for a prescribed period of time (a priming 
time of either 1 h or 2.5 h) or no time at all (priming time of 0 h); FN-coated dishes were 
placed on an incubator rack, while PH-coated dishes were placed in the incubator on a 
rocker and gently rocked.  Growth factor stimulation was achieved by adding 1 mL of 
growth factor stimulation medium (serum-free medium supplemented with EGF, PDGF, 
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or bFGF, as described in the text) to each dish so that concentration of growth factor was 
equivalent in both adherent and suspended dishes.  FN-coated and PH-coated dishes were 
then incubated as described above.   
 
  After being allowed to acclimate (or prime) to their new surface for varying 
lengths of time, as described in the text, cells were stimulated with the indicated amount 
of EGF (Peprotech 100-15), PDGF (Sigma P4306), or bFGF (Sigma F0291).  At desired 
times, Fn-coated dishes were washed twice with cold dPBS, and dishes were tilted and 
rested on ice for 1 to 2 minutes to allow dPBS to collect.  The collected dPBS is then 
aspirated away.  This procedure minimized the amount of diluting the cell lysate, thereby 
enhancing the protein concentration of the recovered lysate.   Cells were lysed by adding 
55 μL of lysis buffer [50 mM Tris (pH 7.5), 150 mM sodium chloride, 50 mM β-
glycerophosphate (pH 7.3), 10 mM sodium pyrophosphate, 30 mM sodium fluoride, 1% 
Triton X-100, 1 mM benzamidine, 2 mM EGTA, 100 μM sodium orthovanadate, 1 mM 
dithiothreitol, 10 µg/mL aprotinin, 10 µg/mL luepeptin, 1 µg/mL pepstatin, and 1 mM 
PMSF] to each dish.  Lysis buffer was added by touching the pipette tip to the upper 
surface of the dish and moving in a horizontal line as lysis buffer was added drop-wise.  
This procedure minimized the volume of lysis buffer needed to obtain full coverage of 
the 60 mm dish and contributed to higher protein concentration in the recovered lysates.  
The cells (on FN-coated dishes) were scraped into the lysis buffer and allowed to lyse for 
approximately 15 min.  
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For PH-coated dishes, cells were collected and centrifuged at 214.6 RCF for 2 
min and liquid was aspirated.  Cells were washed twice with 10 mL cold dPBS.  The tube 
was placed on ice for 1-2 min to allow extra dPBS to collect.  Most of the excess dPBS is 
then aspirated away and the very last bit was manually removed with a pipette.  50 μL of 
lysis buffer was added to each tube, cells were triturated in the lysis buffer, and allowed 
to lyse identically to cells on FN-coated dishes.   
 
Lysates were centrifuged at 16060 RCF for 10 min, and the supernatant was 
collected using gel-loading tips to exclude residual cell debris in the suspension.  Micro-
BCA protein determination (Pierce 23235) was used to determine total protein 
concentration. 
4.4     Immunoblotting 
 
Whole cell lysates were resolved in 10% SDS-polyacrylamide gel electrophoresis 
and blotted onto a PVDF membrane.  Blots were probed using either an antibody against 
dually phosphorylated Erk (Cell Signaling 9101L), phosphorylated Akt (Cell Signaling 
9271L), or Erk2 (Santa Cruz SC-154).  To assay Sos (Santa Cruz SC-256) 
hyperphosphorylation, a 7% polyacrylamide gel electrophoresis was used for enhanced 
resolution of high-molecular-weight molecules.   To assay caspase 3 (Upstate 06-529), a 
15% polyacrylamide gel electrophoresis was used for enhanced resolution of low- 
molecular-weight molecules.  Blots were imaged and quantified as described in the 
Results and Discussion section.  
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4.5     Antibody incubation time optimization  
 
We developed two antibody incubation protocols: one for short antibody 
incubation times, and one for long antibody incubation times.  For optimization of the 
long antibody incubation time protocol, we investigated four different incubation 
conditions:  
1. primary for 1h at room temperature (RT); secondary for 1 h at RT 
2. primary overnight at 4 ºC, secondary 1 h at RT 
3. primary overnight at 4 ºC, secondary overnight at 4 ºC 
4. primary ~24 h at 4 ºC, secondary ~24 h at 4 ºC.   
 
Results from this test revealed a significant difference in imaging based on the 
time and temperature of the primary and secondary antibody incubations.  The highest 
signal-to-noise ratio and best linearity of the employed standard curves occurred for 
primary and secondary incubations that occurred overnight at 4 ºC.  Following this 
optimized incubation protocol resulted in significantly reducing the number of blots that 
had to be rerun, either due to poor estimation of image acquisition time or low signal-to-
noise ratio. 
 
We then began development of an optimal short antibody incubation time 
protocol.  Our hope was to be able to develop a protocol requiring shorter antibody 
incubation times that would yield equivalent results to our long antibody incubation time 
protocol.  In order to achieve this goal, we experimented with many different 
combinations of antibody incubation times including:  
 
1. primary antibody for 2 h at RT; secondary antibody for 2 h at RT 
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2. primary antibody for 1.5 h at RT; secondary antibody for 1.5 h at RT 
3. primary antibody for 1.25 h at RT; secondary antibody for 1.25 h at RT 
4. primary antibody for 1 h at RT; secondary antibody for 1 h at RT 
5. primary antibody for 1.25 h at RT and 5 – 8 h at 4 ºC; secondary antibody 
incubations for 1.5 h at RT.   
6. primary antibody for 1.25 h at RT and 5 – 8 h at 4 ºC; secondary antibody 
incubations for 1.25 h at RT and 5-8 hr at 4 ºC or 1.5 h at RT.   
 
We found that primary antibody incubations times of 1.25 h at room temperature 
and 5-8 h at 4 ºC, followed by secondary antibody incubation times of either 1.5 hours at 
room temperature or 1.25 h at room temperature followed by 5 to 8 h at 4 ºC produced 
nearly identical results.   Thus, our optimal long incubation time protocol requires 
primary antibody incubations overnight at 4 ºC and secondary antibody incubations 
overnight at 4 ºC, while our optimal short incubation time protocol requires primary 
antibody incubations for 1.25 h at room temperature and 5-8 h at 4 ºC, followed by either 
1.5 h at room temperature or 1.25 hours at room temperature and 5-8 hours at 4 ºC.  The 
resulting optimized antibody conditions and lysates amount to load for each antibody of 
interest are shown in Table II-1. 
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Chapter III.    Selective Desensitization of Growth Factor Signaling by 
Cell Adhesion to Fibronectin 
 
1. Abstract  
 
Cell adhesion to the extracellular matrix is required to execute growth factor-
mediated cell behaviors, such as proliferation.  A major underlying mechanism is that cell 
adhesion enhances growth factor-mediated intracellular signals, such as extracellular 
signal-regulated kinase (Erk).  However, because growth factors use distinct mechanisms 
to activate Ras-Erk signaling, it is unclear whether adhesion-mediated enhancement of 
Erk signaling is universal to all growth factors.  We examined this issue by quantifying 
the dynamics of Erk signaling induced by epidermal growth factor (EGF), basic 
fibroblast growth factor (bFGF), and platelet-derived growth factor (PDGF) in NIH-3T3 
fibroblasts.  Adhesion to fibronectin(FN)-coated surfaces enhances Erk signaling elicited 
by EGF, but not by bFGF or PDGF.  Unexpectedly, adhesion is not always a positive 
influence on growth factor-mediated signaling.  At critical sub-saturating doses of PDGF 
or bFGF, cell adhesion ablates Erk signaling; that is, adhesion desensitizes the cell to 
growth factor stimulation, rendering the signaling pathway unresponsive to growth factor.  
Interestingly, the timing of growth factor stimulation proved critical to the desensitization 
process.  Erk activation significantly improved only when pre-exposure to adhesion was 
completely eliminated; thus, concurrent stimulation by growth factor and adhesion was 
able to partially rescue adhesion-mediated desensitization of PDGF- and bFGF-mediated 
Erk and Akt signaling.  These findings suggest that adhesion-mediated desensitization 
occurs with rapid kinetics and targets a regulatory point upstream of Ras and proximal to 
growth factor receptor activation.  Thus, adhesion-dependent Erk signaling is not 
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universal to all growth factors, but rather is growth factor-specific with quantitative 
features that depend strongly on the dose and timing of growth factor exposure.  
 
 
2. Introduction 
 
Cell adhesion plays a key role in regulating cellular behaviors such as gene 
expression, cell survival, and proliferation.  Normal cells deprived of adhesion to the 
extracellular matrix undergo cell cycle arrest (1,2) and programmed cell death, even 
when soluble growth and survival cues are present (1,43-45).  This adhesion-dependence 
is often de-regulated during cancer development, allowing transformed cells to acquire 
growth and survival advantages over their normal counterparts (46-48).  Adhesion-
independent survival and proliferation play a role not only in the build-up of cell mass 
during tumor formation, but also in the survival of cancer cells in foreign, secondary sites 
during metastasis (46,49,50). 
 
Because of the physiological importance of adhesion-mediated cell regulation, 
significant attention has been given to uncovering the underlying signaling mechanisms.  
One prominent point of crosstalk between adhesion and growth factors involves the 
serine/threonine kinase, extracellular signal-regulated kinase (Erk).  Several reports have 
shown that growth factor-mediated Erk signaling is enhanced among cells adhered to 
extracellular matrix (ECM) proteins (2,4,12,13,15-18,24,29,32).  In fact, this adhesion-
mediated enhancement of Erk signaling plays a crucial role in cell cycle regulation.  In 
NIH-3T3 fibroblasts, suspended cells trigger only a transient Erk signal; however, when 
  
III-3
adhered to FN, growth factor treatment supports both a sustained Erk signal and 
subsequent progression through the cell cycle (24).   
 
Erk is a major signaling protein that is activated by a wide array of stimuli, 
including several growth factors such as PDGF, bFGF, and EGF (51-53).  It is unclear 
whether adhesion enhances Erk signaling in response to all of these growth factors, or 
whether only a subset of growth factors signal in an adhesion-dependent manner.  Growth 
factors use substantially different mechanisms to trigger Erk signaling.  Unlike EGF, 
bFGF binding to the cell surface is mediated by two distinct families of cell surface 
receptors (52).  Following ligand binding, EGF receptors are phosphorylated on key 
tyrosine residues that recruit signaling proteins.  In contrast, bFGF receptors 
phosphorylate the multidocking protein FSR2, which subsequently serves as a scaffold to 
trigger downstream signaling pathways.  In addition to activation pathways, growth 
factors differ in negative feedback mechanisms that desensitize signaling (54,55).  For 
example, while stimulation via EGF and PDGF result in serine/threonine phosphorylation 
of their respective receptors, this receptor phosphorylation results in Erk inhibition only 
in the cells stimulated by PDGF.  Interestingly, Erk activation in EGF-stimulated cells 
remain unaffected (54).  Such differences in growth factor signaling mechanisms raise 
the hypothesis that growth factors may differ in the extent to which their stimulation of 
Erk signaling is adhesion-dependent.  
 
To begin to test this hypothesis, we measured the effect of cell adhesion on Erk 
signaling by three growth factors (EGF, bFGF, and PDGF).  In order to measure the level 
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of adhesion-dependence on both the magnitude and dynamics of the Erk signal, we 
implemented a quantitative protocol for Western blot imaging and analysis.  This 
quantitative approach revealed that adhesion-dependent Erk signaling is selective to EGF 
in NIH-3T3 fibroblasts.  Furthermore, our data reveal that adhesion is not always a 
positive influence on growth factor-mediated Erk signaling.  At a critical sub-saturating 
dose of PDGF and bFGF, cell adhesion actually thwarts Erk signaling.  Our results show 
that adhesion desensitizes cells from subsequent growth factor-mediated activation of 
Erk; that is, adhesion renders the signaling pathway unresponsive to growth factor 
treatment.  Interestingly, reducing the duration of cell adhesion prior to growth factor 
stimulation proved critical in the desensitization process.  Thus, PDGF- and bFGF-
mediated Erk signaling significantly improved among adherent cells only when pre-
exposure to adhesion was completely eliminated; however, concurrent stimulation by 
growth factors and adhesion was only able to partially neutralize growth factor-mediated 
desensitization.  Our findings suggest that adhesion-dependence of Erk signaling is not 
universal to all growth factors, but rather is growth factor-specific with quantitative 
features that depend strongly on the dose and timing of adhesion and growth factor 
exposure.  
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3. Experimental Procedures 
 
3.1     Cell maintenance  
 
NIH-3T3 fibroblasts (ATTC) were cultured and maintained in 89% DMEM 
(Gibco), 10% DCS + Fe (Gibco), 1% PenStrep (Gibco).  After approximately 2 d of 
growth, when cells reached between 70-80% confluence, subconfluent cells were 
suspended using 0.25% trypsin-EDTA (Gibco) and reseeded onto tissue culture dishes.    
 
3.2     Protein-coating surfaces 
 
Fibronectin (FN)-coated surfaces were prepared by incubating 2 mL of 5 µg/mL 
FN (Sigma) diluted in Dulbecco’s phosphate buffered saline (dPBS) (Sigma) in tissue 
culture dishes overnight at 4 ºC.  The dishes were gently rocked during adsorption.  The 
dishes were then blocked with 1 mg/mL heat-inactivated bovine serum albumin (BSA) in 
dPBS for 1 h at 37 ºC.  Poly-HEMA (PH)-coated surfaces were prepared by incubating 5 
mL of a solution containing 6 mg/mL PH (Sigma) dissolved in 70% biological grade 
ethanol (Sigma) in uncovered tissue culture dishes overnight at room temperature.   
3.3     Cell adhesion experiments  
 
NIH-3T3 cells were suspended using 0.25% trypsin-EDTA, reseeded, and grown 
until 70-80% confluent.  Subconfluent dishes were starved in completely serum-free 
medium (99% DMEM (Gibco), 1% PenStrep (Gibco), 1 mg/mL BSA (Sigma)) for 20 h 
to bring adhesion signals back to basal levels.  Serum-starved cells were suspended using 
0.05% trypsin; trypsin activity was quenched by adding soybean trypsin inhibitor (Sigma) 
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to a final concentration of 0.5 mg/mL.  Cells were re-suspended in serum-free medium to 
a concentration of 5 x 105 cells/mL and were either plated onto FN-coated dishes or PH-
coated dishes; PH-coated dishes were rocked to prevent cell aggregation.   
 
After cells acclimated to the surface for varying lengths of time (either 2.5 h, 1 h, 
or 0 h, as described in the text), cells were stimulated with the indicated amount of either 
PDGF (Sigma), bFGF (Sigma), or EGF (Peprotech).  Cells were lysed in buffer 
containing 50 mM Tris (pH 7.5), 150 mM sodium chloride, 50 mM β-glycerophosphate 
(pH 7.3), 10 mM sodium pyrophosphate, 30 mM sodium fluoride, 1% Triton X-100, 1 
mM benzamidine, 2 mM EGTA, 100 μM sodium orthovanadate, 1 mM dithiothreitol, 10 
μg/mL aprotinin, 10 μg/mL leupeptin, 1 μg/mL pepstatin, and 1 mM PMSF.  Lysates 
were incubated in lysis buffer for 15 min on ice before centrifugation and collection of 
the supernatant.  Micro-BCA Protein Assay Kit (Pierce) was used to determine total 
protein concentration.  
 
3.4     Immunoblotting 
 
Whole cell lysates were resolved by 10% SDS-polyacrylamide gel electrophoresis 
and blotted onto a PVDF membrane.  Blots were probed using either an antibody against 
dually phosphorylated Erk (Cell Signaling), S473 phosphorylated Akt (Cell Signaling), 
Erk2 (Santa Cruz), Sos (Santa Cruz), or caspase 3 (Upstate).  In the cases of Sos and 
caspase 3, a 7% and 15% gel were used to better resolve high- and low-molecular-weight 
proteins, respectively.  Blots were imaged and quantified as described in the Results 
section.  
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4. Results  
 
4.1     EGF, but not PDGF and bFGF, induces adhesion-dependent Erk activation 
 
Using the quantitative Western blotting protocol described in detail in Chapter 2, 
we measured the Erk signaling response to growth factor treatment of cells adhered on 
FN or held in suspension.  Our initial experiments used growth factor concentrations well 
above the dissociation constant (Kd) (Table III-1).  
 
 
Table III-1: Summary of growth factor properties including the critical 
concentration at which adhesion-mediated desensitization occurs.  
 
 
Growth 
Factor 
MW 
(kDa) 
Kd 
(pM)  
Critical concentration, [GF]c 
(pM) 
EGF 6.20 670 (56) N/A 
PDGF 24.6 100-1000 (57-63) 8.1 
bFGF 16.4 30 (64,65)a 1.2 
 
a At low concentrations, bFGF will bind almost exclusively to high-affinity sites (64), 
thus, the reported Kd corresponds to bFGF interaction with its high-affinity receptor. 
 
At these saturating growth factor concentrations, EGF-mediated Erk signaling is 
enhanced by cell adhesion.  Cells adhered on FN exhibit approximately 3-fold greater Erk 
activation than cells held in suspension in response to treatment with EGF for 12 min 
(Figure III-1).  Meanwhile, neither bFGF- nor PDGF-mediated Erk signaling at a single 
early time-point are adhesion-dependent (Figure III-1A).  These results suggest that some 
growth factors (EGF) signal better via the Erk pathway when in an adhesive setting, 
while other growth factors (PDGF, bFGF) promote Erk signaling in an adhesion-
independent manner. 
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Figure III-1: Adhesion-dependence of Erk signaling at saturating concentrations of growth 
factors.  
 Serum-starved cells were either held in suspension via PH-coated dishes or allowed to adhere 
on FN-coated dishes for 2.5 hr prior to stimulation with serum-free medium containing a single 
growth factor at the indicated concentrations.  After the desired time of exposure to growth 
factor, cells were lysed, and lysates were analyzed via Western blot with the anti-phospho-Erk 
and anti-Erk antibodies.  The relative amount of active Erk (ppErk) normalized to the equal-
loading control, total Erk (ErkT), is reported for the different treatment conditions. (A) 
Adhesion enhances Erk signaling in response to EGF, but not bFGF or PDGF, 
stimulation.  Cells held in suspension (empty) and those adhered to FN (filled) were 
stimulated with the indicated growth factor-containing medium or with serum-free medium 
(SF) and were lysed after 12 min of stimulation.  Error bars represent sample standard errors (n 
= 2-9).  The single asterisk denotes that Erk activation in the suspended and adherent cells is 
statistically similar.  The double asterisk denotes that ERK activation in the suspended and 
adherent cells is statistically different (P < 0.01) using Student’s t-test. (B) Adhesion enhances 
EGF-mediated Erk signaling over the entire time course.  Cells held in suspension (empty 
circles) or allowed to adhere on FN (solid square) were stimulated with 800 pM EGF for the 
indicated times.  Error bars represent sample standard errors (n=2-4).  The double asterisk 
denotes that ERK activation in the suspended and adherent cells is statistically different with P 
< 0.05 (6 min.)  and P < 0.09 (12 min.).  All P values were computed using Student’s t-test.  
(C)  PDGF activates Erk in an adhesion-independent manner over the entire time course. 
Cells held in suspension (empty circles) or allowed to adhere on FN (solid squares) were 
stimulated with 800 pM PDGF for the indicated times.  Error bars represent sample standard 
errors (n = 2-4).  The single asterisk denotes that ERK activation in the suspended and adherent 
cells is not statistically different using Student’s t-test. 
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These observations are based on a single, early time-point.  However, others have 
shown that growth factor-mediated Erk signaling may exhibit different dynamical 
features in adhered versus non-adhered cells (15,22,24,29).  For example, in both adhered 
and suspended cells, PDGF stimulates Erk equivalently at early times, but only the 
adhered cells maintain a sustained Erk signal (22).  To examine whether adhesion affects 
the dynamics of growth factor-mediated Erk signaling, we measured a full time-course of 
Erk signaling in response to each of the three growth factors.  For EGF-stimulated cells, 
the early phase of Erk activation (< 1 h) is adhesion-dependent, while the late phase of 
the signal reaches a nearly equivalent, basal signal for both adhered and suspended cells 
(Figure III-1B).  Furthermore, both the adherent and suspended cells reach maximum 
signal intensity after only 6 min of stimulation.  Thus, the kinetics of EGF-induced Erk 
signaling is similar in both adherent and suspended cells, although signal magnitude is 
clearly adhesion-dependent.   
 
In contrast, Erk activation in cells stimulated with either PDGF (Figure III-1C) or 
bFGF (Supplemental Figure VI-1, see page VI-1) was adhesion-independent.  For both 
growth factors, the Erk signal reached a similar maximum after approximately 30 min of 
stimulation.  Furthermore, in the case of PDGF, the Erk signal decays with similar 
kinetics for both suspended and adhered cells.  In the case of bFGF, however, the Erk 
signal is sustained at near-maximum levels in both adhered and suspended cells.  Thus, 
measurements of the complete dynamics of Erk signaling show that EGF, but not PDGF 
or bFGF, induces Erk signaling in an adhesion-dependent manner.   
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4.2     Sub-saturating doses of PDGF or bFGF reveal negative adhesion-growth factor 
synergism 
 
The apparent lack of adhesion-dependence in Erk signaling for bFGF and PDGF 
may be linked to the fact that high concentrations of the growth factors were used.  In this 
concentration regime, excessive growth factor signaling may overcome the need for cell 
adhesion.  Thus, we hypothesized that for PDGF and bFGF, Erk signaling may be 
adhesion-dependent if concentrations near or less than Kd (Table III-1) were used.  To 
test this possibility, we measured growth factor-mediated Erk signaling across a broad 
range of growth factor concentrations.   
 
In the case of EGF, varying its concentration over three orders of magnitude did 
not affect the observed adhesion-mediated enhancement in Erk signaling (Figure III-2A).  
Regardless of its concentration, EGF stimulated an approximately 3-fold greater Erk 
response among adherent cells than among suspended cells (Figure III-2A).  In contrast, 
experiments with different PDGF and bFGF concentrations revealed an unexpected 
response (Figure III-2B and Figure III-2C).  At a critical growth factor concentration (8 
pM PDGF or 1 pM bFGF), cells in suspension induced Erk signaling to a significantly 
greater extent than did adherent cells.  Above the critical PDGF and bFGF concentration, 
adhered and suspended cells responded equivalently (Figure III-2B and Figure III-2C).  
At the critical PDGF and bFGF concentration, the suspended cells responded 7-fold and 
13-fold better, respectively, than their adherent counterparts (Figure III-2B and Figure 
III-2C).  These results reveal a negative synergism between adhesion and growth factor 
stimulation: adhesion thwarts Erk activation at critically low doses of PDGF and bFGF.   
 
  
III-11
 
A 
 
B 
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Figure III-2: Adhesion-dependence of Erk signaling across a wide range of growth 
factor doses.  
 NIH-3T3 cells were treated as described in the legend to Figure III-1, except that cells were 
stimulated with serum-free medium containing different doses of (A) EGF for 12 min, (B) 
PDGF for 30 min or (C) bFGF for 30 min.  The response of cells held in suspension (empty) 
is compared to cells adhered on FN (filled).  (A) Error bars represent sample standard errors 
(n=2-4).  The double asterisk denotes that ERK activation in suspended and adherent cells is 
statistically different with P < 0.001 (800 pm) and P < 0.07 (80 pm).  (B) Error bars represent 
sample standard errors (n=2-4).  The double asterisk denotes that ERK activation in 
suspended and adherent cells is statistically different with P < 0.04.  (C) Error bars represent 
sample standard errors (n=2-4).  The double asterisk denotes that ERK activation in the 
suspended cells is statically different with P < 0.07.  All P values were computed using 
Student’s t-test.    
 
 
Since this negative synergy was observed at a specific time point in Erk signaling, 
we investigated the dynamics of Erk signaling more completely at the critical PDGF 
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concentration (Figure III-3) and bFGF concentrations (Supplemental Figure VI-2, see 
page VI-1).  At the critical PDGF concentration, adherent cells were unable to induce Erk 
signaling during the entire time course (Figure III-3).  In contrast, Erk signaling in 
suspended cells was substantial throughout the entire time course (Figure III-3).  Thus, 
the observed negative synergism between adhesion and growth factor stimulation is not 
an artifact of selecting a specific time point; rather, the entire dynamics of PDGF-
mediated Erk signaling is suppressed among adherent cells at the critical PDGF 
concentration.  Similar results were observed for bFGF as adhesion completely ablated 
bFGF-mediated Erk activation (Supplemental Figure VI-2, see page VI-1).   
 
 
 
Figure III-3:  Time course of adhesion-dependent Erk signaling at the critical PDGF 
concentration.   
Serum-starved NIH-3T3 cells were held in suspension (empty circles) or adhered on FN (solid 
squares) as described in the legend to Figure III-1.  Cells were stimulated with serum-free 
medium containing 8 pM PDGF and lysed at the indicated times.  The relative amount of 
active Erk normalized to total Erk is reported.  Error bars represent sample standard errors (n = 
2-4). 
 
4.3     Adhesion desensitizes PDGF- and bFGF-mediated Erk signaling 
 
The observed negative synergy reveals that cell adhesion to FN selectively 
abrogates PDGF- and bFGF-mediated Erk signaling when these growth factors are 
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present at low concentrations.  These observations raise the possibility that adhesion 
desensitizes subsequent Erk activation.  Desensitization refers to a state in which a 
signaling pathway becomes unresponsive to stimuli.  This desensitized or refractory state 
may occur when a signal triggers negative feedback mechanisms that persist and prevent 
re-activation of the signal in response to new stimuli.  Published reports have shown that 
growth factor stimulation inhibits Erk signaling in response to a second challenge of 
growth factor (66-68).  Our results suggest that adhesion to FN may also desensitize Erk 
signaling to a select subset of growth factors (PDGF and bFGF).   
 
 
 
 
 
 
 
Figure III-4: Adhesion-mediated Erk activation.   
Serum-starved NIH-3T3 cells were suspended and re-plated on FN-coated plates as described 
in the legend of Figure III-1.  Cells were lysed at the indicated times after plating without 
growth factor stimulation.  Lysates were analyzed by SDS-PAGE and Western blotting with 
an anti-phospho-Erk antibody (top panel) and an anti-Erk antibody (bottom panel) as an equal 
loading control. 
 
 
 
Consistent with this hypothesis of adhesion-mediated desensitization, cell 
adhesion to FN in the absence of growth factors promotes Erk activation (Figure III-4).  
Adhesion rapidly stimulates the Erk pathway with maximal activation occurring by 
approximately 12 min after cell seeding. This adhesion-mediated Erk signaling may 
trigger negative feedback loops that desensitize cells to subsequent Erk signaling by 
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PDGF and bFGF.  If desensitization is responsible for reduced PDGF- and bFGF-
mediated Erk signaling, then reducing the duration of cell adhesion prior to growth factor 
stimulation might alleviate this suppression.  As cells were seeded 2.5 hr prior to  
 
 
A 
 
B 
 
C 
 
Figure III-5: The dependence of PDGF-mediated ERK signaling on the duration of 
pre-exposure to FN-coated surfaces.   
Serum-starved NIH-3T3 cells were held in suspension (empty circles) or adhered on FN-
coated plates (solid squares) as described in the legend to Figure III-1.  The duration cells 
spent in suspension or adhered to FN prior to stimulation with 8 pM PDGF was reduced 
from 2.5 h to (A) 1 h or (B) 0 h.  The integral of the ERK time-course for all three 
acclimation times are shown in (C).  For A and B, error bars represent sample standard 
errors (n = 3-6).  For C, the error bars represent propagated error when the trapezoid rule is 
used to calculate the integrated signal.    
 
 
 
stimulation in all previous experiments, we tested this hypothesis by measuring PDGF-
mediated Erk signaling among cells that were exposed to FN-coated surfaces for shorter 
  
III-15
times, specifically 1 h and 0 h (Figure III-5A and Figure III-5B, respectively).  In the 0 h 
case, cells were concurrently stimulated with growth factor and plated onto FN-coated 
dishes. 
 
Reducing the duration of adhesion significantly enhanced PDGF-mediated Erk 
signaling among adherent cells.  While Erk signaling was severely attenuated among 
cells that had adhered for 2.5 h (Figure III-3), reducing adhesion time to 1 h only slightly 
improved Erk signaling (Figure III-5A).  However, eliminating pre-exposure to adhesion 
altogether by concurrent stimulation with PDGF significantly improved Erk signaling 
among adherent cells (Figure III-5B).  In order to quantify the enhancement in PDGF-
mediated Erk signaling in response to decreasing the duration of adhesion, we integrated 
the time course of Erk signaling for cells held in suspension or adhered on FN for 0 h, 1 h 
and 2.5 h (Figure III-5C).  When the pre-exposure time to adhesion is reduced from 2.5 h 
to 0 h, the integrated Erk signal increases approximately 5-fold.  Notably, even 
concurrent stimulation was unable to rescue PDGF-mediated Erk activation to the same 
level as that observed in suspended cells, suggesting that adhesion-mediated 
desensitization occurs rapidly.  The rapid timescale of adhesion-mediated desensitization 
is consistent with the fact that cell adhesion to FN significantly activates Erk within 12 
min of cell seeding (Figure III-4).  
 
4.4     Mechanisms underlying adhesion-mediated desensitization 
 
The hyperphosphorylation of Sos is a prominent mechanism in growth factor-
mediated desensitization of Erk (69-73).  To determine whether cell adhesion to FN 
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desensitizes the Erk pathway in a similar manner, we measured the effect of cell adhesion 
on the hyperphosphorylation of Sos using a gel retardation assay (Figure III-6).  The 
mobility of Sos did not change among cells that were plated on FN-coated substrates in 
the absence of growth factor (Figure III-6, lanes 1-7).  In contrast, a positive-control 
treatment with PDGF induces a clear and significant retardation in Sos mobility (Figure 
III-6, lane 10).  Thus, adhesion-mediated desensitization of Erk signaling does not 
involve hyperphosphorylation of Sos. 
 
 
Figure III-6: The effect of cell adhesion on Sos hyperphosphorylation.  
 Serum-starved NIH-3T3 cells were suspended and re-plated on FN-coated plates as described 
in the legend of Figure III-1.  Cells were lysed at the indicated times after plating without 
growth factor stimulation.  Lysates were analyzed by SDS-PAGE and Western blotting with 
an anti-Sos antibody.  A shift in total Sos indicates presence of the hyperphosphorylated form 
of Sos.  Lanes 8 and 9 represent negative unstimulated controls for Sos hyperphosphorylation.  
Lane 8 contains cells that have been held in suspension for 2.5 h, while lane 9 represents cells 
that have been adhered to FN to 2.5 h.  Lane 10 represents the positive control for the 
hyperphosphorylated form of Sos and contains cells that have been adhered to fibronectin for 
2.5 h prior to stimulation by 800 pM PDGF for 12 min.   
 
To determine whether adhesion-mediated suppression of PDGF and bFGF 
signaling was specific to the Erk pathway, we measured Akt signaling under similar 
conditions.  PDGF- and bFGF-mediated Akt phosphorylation was also significantly 
diminished among adherent cells (Figure III-7 and Supplemental Figure VI-3 on page VI-
2, respectively).  In addition, PDGF-mediated Akt activation among adherent cells 
significantly improved as adhesion time on FN was decreased (Figure III-7).  While  
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Figure III-7: Adhesion-dependence of PDGF-mediated Akt signaling.   
Serum-starved NIH-3T3 cells were held in suspension (empty circles) or adhered on 
FN (solid squares) for 2.5 h as described in the legend to Figure III-1.  Cells were then 
treated with PDGF and lysed at the indicated time-points.  The level of 
phosphorylated Akt (pAkt) was quantified and normalized to the amount of total 
cellular Erk (ErkT).  The duration for which cells were either held in suspension or 
adhered on FN was reduced from (A) 2.5 h to (B) 1 h or (C) 0 h.  The integrated area 
for all three acclimation times is shown in (D).  For A and B, error bars represent the 
sample standard errors (n = 3-6).   For D, the error bars represent propagated standard 
error when the trapezoid rule is used to approximate the integrated signal.    
 
reducing the duration of adhesion from 2.5 h to 1 h only slightly improved Akt signaling 
(compare Figure III-7A and Figure III-7B), concurrent stimulation significantly improved 
Akt signaling among adherent cells (Figure III-7C).  Indeed, the integrated Akt signal 
shows a trend identical to that of the integrated Erk signal.  While the integrated Akt 
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signal for suspended cells remains constant, for adherent cells, the signal clearly increases 
as the duration of adhesion on FN is reduced (Figure III-7D).  Because adhesion 
suppresses both Erk and Akt signaling, it suggests that adhesion-mediated desensitization 
of PDGF and bFGF signaling may occur at or above the level of Ras activation, but 
independent of Sos regulation.  
  
5. Discussion  
 
This study demonstrates that cell adhesion has quantitatively intricate effects on 
growth factor-mediated Erk signaling.  We report that the effect of cell adhesion is 
specific to the type of growth factor, its dose, and the timing of stimulation.   Our system 
exclusively uses NIH-3T3 fibroblasts that are stimulated in defined medium.  We find 
that adhesion to FN selectively enhances Erk signaling elicited by EGF, but has no effect 
on bFGF- or PDGF-mediated Erk activation.  Unexpectedly at concentrations of PDGF 
and bFGF (GFc) that are significantly less than Kd (Table III-1), cell adhesion severely 
attenuates growth factor-mediated Erk signaling.  Thus, adhesion not only enhances cell 
response to specific growth factors, but also filters out potentially noisy signals from low 
levels of growth factor.  This aspect of adhesion-growth factor crosstalk may play an 
important role in buffering cell response to noisy background levels of growth factor 
stimulation.  These results reveal that the crosstalk between adhesion and growth factor 
signaling has intricate quantitative features, consistent with the extensive connectivity 
between adhesion and growth factor signaling pathways (53,74,75). 
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Our observation that adhesion to FN enhances EGF-mediated Erk signaling is 
consistent with other reports (21).  Our results further demonstrate that adhesion does not 
enhance either PDGF- or bFGF-mediated Erk signaling in NIH-3T3 cells, a finding that 
is contrary to some reports (15,22,24,29).  In one such report, bFGF treatment was found 
to induce sustained Erk signaling that supports cell cycle progression of NIH-3T3 
fibroblasts seeded on FN-coated surfaces (76).  However, the 3T3 cells used express 
exogenous human α5β1 integrin, whereas our cell system expresses only endogenous 
integrin adhesion receptors.  Furthermore, both the aforementioned study and others 
using NIH-3T3 cells supplement the growth factor-containing medium with serum 
(24,29).  This serum supplement is essential to maintain long-term cell viability, a clear 
requirement for studying cell cycle progression.  Our studies, in contrast, employ serum-
free medium supplemented with specific growth factors.  We have carefully assayed cell 
death under serum-free conditions by trypan blue staining and by Western blotting for 
caspase 3 cleavage (data not shown).  Our measurements show that cells held in 
suspension or adhered on FN-coated plates remain viable for 4-5 hr in serum-free 
conditions.  Thus, all reported results are gathered in this time window and offer a clear 
indication of how Erk signaling by each growth factor is influenced by adhesion without 
confounding contributions from serum.  
 
In addition to serum, cell type differences may also contribute to apparent 
differences in adhesion-dependence of Erk signaling.  Kazlauskas and colleagues showed 
that PDGF treatment of mouse embryo fibroblasts (MEFs) adhered on FN induces 
sustained Erk activation, whereas cells seeded on poly-L-lysine support only a transient 
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Erk signal (22).  The difference between our results and those of Kazlauskas and 
colleagues may be due to the use of MEF versus NIH-3T3 cells.  Moreover, the MEF 
strain used in the study lacks PDGFRα and expresses endogenous PDGFRβ; our NIH-
3T3 cells express both isoforms.  Thus, the complement of homo- and heterodimer 
receptors available for binding PDGF-BB and for intracellular signaling are likely to be 
different in these two cell types.   
 
Because of both the differences in cell types and receptor expression profiles, as 
well as the potentially confounding contributions from serum, it remains unclear whether 
adhesion-dependent Erk signaling is specific to particular growth factors.  We sought to 
address this issue by developing a system that utilizes only NIH-3T3 fibroblast cells 
expressing endogenous integrins.  Furthermore, growth factor stimulation was limited to 
use of only one growth factor in defined medium, thus no serum was used during the 
course of the experiments.  Thus, our data begins to provide a systematic comparison of 
the crosstalk between adhesion and three different growth factors.  We show that 
adhesion to FN enhances Erk signaling elicited by EGF, but not by bFGF and PDGF.  
Our observation that adhesion-mediated enhancement of Erk signaling is not a universal 
property of all growth factors is consistent with our previous findings in Chinese hamster 
ovary (CHO) cells.  In these cells, the dynamics and magnitude of insulin-mediated Erk 
signaling are unaffected by cell adhesion to FN (14).  Rather, adhesion and insulin 
synergistically affected IRS-1 phosphorylation en route to co-regulating cell cycle 
activity.   
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The specificity of adhesion-dependence might be explained by intrinsic 
differences in how the receptors of these growth factors signal to Erk.  Although all three 
growth factors employ the canonical Ras-MAP kinase cascade to activate Erk, there are 
significant differences in the upstream machinery that connect to the core Ras/MAP 
kinase signaling module. While EGF receptors recruit the necessary signaling proteins 
mostly by themselves (52), FGF receptors rely on the formation of a multidocking 
signaling protein complex to recruit the majority of signaling components (77).  In 
addition, bFGF binds to two distinct families of cell surface receptors, the first being the 
bFGF receptor tyrosine kinase and the second being heparin sulfate proteoglycans 
(HSPG) (65,78).  The binding to and signaling from two distinct receptor families 
provides additional layers of control and complexity to bFGF-mediated signaling to Erk 
(79).    
 
In addition to utilizing different mechanisms for activating the Ras/MAPK 
module, growth factor receptors differ in their susceptibility to negative regulatory 
mechanisms.  For example, serine/threonine phosphorylation of EGF and PDGF 
receptors has been shown to affect the two receptors differently.  G protein-coupled 
receptor kinase 2 (GRK2) mediated serine/threonine phosphorylation of the PDGF 
receptor results in a decrease in PDGF receptor tyrosine phosphorylation, which 
correlates to an observed decrease in Erk activation by PDGF stimulation (54).  In 
contrast, GRK2 mediated serine/threonine phosphorylation has no effect on the tyrosine 
phosphorylation of the EGF receptor and subsequent Erk activation is also not affected.  
In summary, there are distinct pathways by which growth factors activate the Ras/MAPK 
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module as well as differences in growth factor receptor sensitivity to negative regulatory 
mechanisms.  Cell adhesion may also couple to pathways unique to EGF, thereby 
selectively enhancing EGF-mediated Erk signaling. 
 
While adhesion selectively enhances EGF-mediated Erk signaling at saturating 
growth factor concentrations, an intriguing feature of adhesion-dependence was found at 
low, sub-saturating doses of growth factors.  PDGF- and bFGF-mediated Erk signaling is 
substantially attenuated among cells adhered on FN.  This adhesion-mediated suppression 
of growth factor-induced Erk signaling is alleviated if the duration of cell adhesion is 
reduced.  These observations suggest that cell adhesion rapidly triggers mechanisms that 
desensitize Erk signaling by low concentrations of PDGF and bFGF.    
 
Desensitization of the ERK signaling pathway has been reported in response to 
growth factor stimulation.  Growth hormone (GH) induces Erk activation in HA cells; 
however, re-exposure to GH in cells that have been pre-treated with this growth factor for 
3 h fails to stimulate ERK (67).  Similar desensitization of Erk activation has been shown 
in insulin-treated CHO/IR cells.  Although Erk activation occurs upon initial insulin 
exposure, a second exposure to insulin fails to induce Erk signaling (68).  Comparable 
insulin-mediated desensitization has been observed in 3T3-LI adipocyte cells (66).  
However, in these cells, insulin pre-treatment does not desensitize EGF-mediated ERK 
activation.  In contrast to insulin and EGF, heterologous desensitization has been 
observed between EGF and PDGF (80).  Swiss-3T3 cells first exposed to PDGF fail to 
induce Erk activation upon a subsequent treatment with either PDGF or EGF.  The 
  
III-23
converse is also observed: initial exposure to EGF inhibits subsequent stimulation of 
ERK signaling by either PDGF or EGF treatment.  Hence, there is precedent for 
desensitization to selectively affect a subset of growth factors. 
 
A prominent mechanism by which growth factor desensitizes ERK signaling in 
response to subsequent growth factor stimulation involves Sos hyperphosphorylation (69-
72).  However, our results demonstrate that adhesion to FN does not induce Sos 
hyperphosphorylation, suggesting that adhesion-mediated desensitization does not occur 
at the level of Sos regulation.   
 
Our results suggest that the time scale of desensitization is remarkably rapid.  
Thus, although Sos is not the target of desensitization, another signal extremely proximal 
to growth factor detection must be involved.  Consistent with this possibility, our results 
show that both Akt and Erk signaling are subject to adhesion-mediated desensitization, 
suggesting that Ras or some other common upstream element is the point of 
desensitization.  In fact, several growth factor receptors directly interact with adhesion 
receptors (81).  While the association of growth factor receptors with adhesion receptors 
has been predominantly correlated with positive synergism, it may also sequester and 
inhibit the activity of low levels of ligand-bound growth factor receptors.  Indeed, such 
heterologous desensitization by receptor sequestration has been demonstrated for EGFR 
and PDGFR (80).  Another possible mechanism of growth factor desensitization may 
involve direct interactions between growth factors and ECM proteins.  Sequestration of 
TGFβ, VEGF, and HGF by ECM is well documented (82).  In fact, VEGF has recently 
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been shown to bind specific sites on FN, suggesting potential sequestration in more basic 
reconstituted systems.   Thus, ECM protein-mediated sequestration may play a role in 
diminishing growth factor-mediated signaling on FN-coated dishes, especially in systems 
employing low doses of growth factor (83). 
 
While elucidating the precise role of these mechanisms is the subject of ongoing 
work in our lab, it is especially intriguing that adhesion-mediated desensitization occurs 
selectively at low growth factor concentrations.  Thus, adhesion may play an important 
role in buffering cell response to noisy, background levels of growth factor stimulation.  
Combined with the ability to enhance signaling for select growth factors, adhesion may 
have a net positive effect on the signal- to-noise ratio of detecting and responding to 
growth factors.  Deciphering these and other quantitatively intricate ways in which cell 
adhesion influences growth factor signaling will be crucial to developing a better 
understanding of how the adhesive microenvironment ‘primes’ cell behaviors.  Such 
quantitative insight will be important in designing synthetic microenvironments for 
applications such as tissue engineering and regenerative medicine.  In addition, 
quantification will enable improved assessment of the quality and effectiveness of both 
biomaterials and cancer therapies. 
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Chapter IV.    Modeling-Guided Inference of Mechanisms Underlying 
Erk Signaling Dynamics 
 
 
1. Abstract 
 
We developed a simple coarse-grain mathematical model to elucidate how 
specific molecular mechanisms contribute to the dynamics of Erk signaling.  Model 
results are compared to experimental Erk signaling profiles to infer potential mechanisms 
and to direct future experiments.  Our model lumps Erk activation and deactivation 
mechanisms into four distinct biological motifs: activation, constitutive direct 
deactivation, feedback-mediated direct-deactivation (a feedback mechanism where the 
active signal upregulates a protein that deactivates it), and feedback-decoupling 
deactivation (a feedback mechanism where the active signal deactivates an upstream 
protein necessary for signal activation).  In the presence of activation stimulus, two types 
of kinetic profiles are observed: (1) transient, where the steady-state signal returns to a 
basal level, and (2) sustained, where the steady-state signal is maintained to at least its 
half-maximal level.  Our model reveals that feedback-decoupling deactivation and one 
form of direct-deactivation are necessary to generate a transient signal, while feedback-
decoupling deactivation in isolation or any form(s) of direct-deactivation results in 
sustained signal activation.  Notably, our model predicts that signal magnitude 
enhancement/depression is most significantly impacted by differences in the activation 
rate constant (κact).  As a difference in peak signal magnitude was experimentally 
observed for adhesion-dependent Erk activation by EGF-stimulation, our model predicts 
that adhesion-induced enhancement is the most likely explanation.  In addition, our 
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model provides insight into potential mechanisms responsible for the difference in Erk 
activation dynamics in adherent cells stimulated by distinct growth factors.  In order to 
determine the mechanistic details responsible for the PDGF/EGF-induced transient Erk 
activation verses the bFGF-induced sustained Erk activation observed for adherent cells, 
a difference in the deactivation motifs acting on these adherent cells must be determined. 
We find that the mechanism responsible for the distinct signaling dynamics resulting 
from stimulation by different growth factors in adherent cells must be due to either 
feedback-decoupling deactivation (for the case where no feedback-decoupling 
deactivation occurs in cells stimulated via bFGF) or direct-deactivation (for the case 
where feedback-decoupling deactivation is the only form of deactivation present in cells 
stimulated via bFGF).  
2. Introduction 
 
The combination of adhesion to the extracellular matrix (ECM) and growth 
factors plays a key role in regulating important cellular functions such as proliferation, 
cell survival, and gene expression.  Because Erk activation has been established as a 
prominent point of cross-talk between adhesion and growth factors, extensive effort has 
been invested in understanding adhesion-mediated Erk signaling.  Synergy in adhesion- 
and growth factor-mediated Erk activation has been described as equivalent (Galownia, 
2006; Mettouchi et al., 2001), as a difference in magnitudes (Asthagiri et al., 2000; 
Marshall, 1995), as a difference in dynamics from transient to sustained (DeMali et al., 
1999; Roovers et al., 1999; Tombes et al., 1998), or not been given any kinetic 
description at all (Lin et al., 1997; Renshaw et al., 1997; Schwartz and Assoian, 2001).  
For clarity, several phrases used to describe signal kinetics will be given precise 
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definitions.  In order for a signal to be classified as ‘transient,’ the temporal profile must 
return to basal.  Alternatively, to be classified as ‘sustained,’ the temporal profile must 
reach and maintain a signal equal to at least half-maximum.  The phrases ‘maximum 
intensity’ and ‘peak intensity’ will be used to describe the largest magnitude in the 
temporal profile. 
 
Because both the kinetic profile and signal magnitude of Erk activation may be 
affected, synergy in Erk signaling likely involves crosstalk not only in activation 
mechanisms, but also across Erk deactivation pathways (Asthagiri and Lauffenburger, 
2001).  Dephosphorylation due to basal phosphatase activity regulates Erk deactivation 
(Keyse, 2000; Lewis et al., 1998; Tamura et al., 2002), a mechanism we term as 
constitutive direct deactivation.  In addition, activation of Erk itself catalyzes its 
deactivation via two separate feedback mechanisms where active Erk:  (1) upregulates 
phosphatase levels (Brondello et al., 1997; Grumont et al., 1996) that deactivate it, a 
feedback mechanism we term feedback-mediated direct deactivation, or (2) deactivates 
its upstream activators (Brunet et al., 1994; Buday et al., 1995; Cherniack et al., 1995; 
Dong et al., 1996; Langlois et al., 1995; Wartmann et al., 1997), a feedback mechanism 
we term feedback-decoupling deactivation.   
 
Our experimental data reveals that adhesion-dependence of Erk signaling is not 
universal to all growth factors, but rather is growth factor-specific (Galownia, 2006).  In 
addition, our experimental data indicates that different growth factors result in distinct 
kinetic Erk activation profiles.  However, precisely what combination of crosstalk 
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between integrins and growth factors underlies the observed synergy in Erk signaling 
remains unclear.  Therefore, in this study we developed a computational model to 
investigate how different activation and deactivation motifs within the Erk signaling 
network contribute to Erk signaling dynamics. Our model predictions are then compared 
to experimental data to narrow down potential mechanism(s) producing the observed 
kinetic profiles.    
 
3. Background 
 
3.1     Activation of MAPK pathway 
 
 
Figure IV-1: Canonical MAPK pathway  
 Growth Factor-receptor binding stimulates receptor autophosphorylation, which 
enables Grb2 binding.  Grb2 then recruits Sos, allowing Sos-mediated Ras 
activation.  Activated Ras triggers a signaling cascade by activating Raf.  Raf 
phosphorylates Mek, which phosphorylates Erk.   
Sos
Grb2 
Ras
Ras
MEK
ERK
Raf
GF
Membrane
GF Receptor 
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In the canonical growth factor-MAPK (mitogen activated protein kinase) pathway 
(Figure IV-1), growth factor ligands bind to receptors and elicit tyrosine 
autophosphorylation of the receptor (Ford and Pardee, 1999; Roovers and Assoian, 
2000).  This enables growth factor receptor bound protein 2 (Grb2) to bind to the receptor 
and recruit the guanosine 5’-triphosphate exchange factor, son-of-sevenless (Sos) 
(Roovers and Assoian, 2000).  Sos-mediated nucleotide exchange activates the Ras G-
protein by converting it to its GTP form, which enables it to bind to and activate Raf 
kinase.  Raf kinase then activates Mek kinase, which activates Erk kinase and eventually 
leads to S-phase entry (Ford and Pardee, 1999; Roovers and Assoian, 2000).   
 
One pathway by which integrins enhance MAPK activation is through direct 
interaction with growth factor receptors themselves (Giancotti and Tarone, 2003; 
Miyamoto et al., 1996).  Integrin-mediated cell adhesion has been shown to induce 
activation of insulin receptor, EGF receptor, PDGF receptor, and bFGF receptor 
(Giancotti and Tarone, 2003; Schlessinger, 2000).   Recent studies have uncovered 
multiple mechanisms by which integrins induce MAPK activation at the level of receptor 
protein tyrosine kinase activation (Giancotti and Tarone, 2003).  In one such mechanism, 
integrin-mediated adhesion has been shown to induce growth factor receptor aggregation 
and the subsequent activation of the MAPK pathway (Miyamoto et al., 1996).    
 
Another mechanism involves integrin-mediated activation of Src.  In this form of 
regulation, a macromolecular complex comprised of the cytoplasmic tail of the EGF 
receptor, p130Cas, and Src form in response to cell adhesion.  Src is required for complex 
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assembly, and complex formation is necessary to enable Src-mediated phosphorylation 
and activation of the EGF receptor.  Once in complex, Src phosphorylates the 
cytoplasmic domain of the receptor on tyrosine residues 845, 108, and 1173, resulting in 
its activation.  Interestingly, Src is unable to phosphorylate the receptor on Tyr1148, which 
is a major site of the receptor phosphorylation by EGF, indicating that distinct 
mechanisms exist by which integrins and growth factors activate the growth factor 
receptor (Moro et al., 2002). 
 
   Alternatively, for integrin- and Src-family kinase-mediated PDGF receptor 
activation, active SFK phosphorylates SIRP-α/SHPS-1, leading to the recruitment of the 
tyrosine phosphatase, SHP-2, to the cell’s membrane.  SHP-2 then associates with PDGF 
receptor and dephosphorylates it at the tyrosine residue mediating binding to Ras-Gap, a 
known negative regulator of Ras.  Ras-Gap activation is efficiently reduced, leading to 
both Ras and subsequent Erk activation.    
 
There are also several mechanisms by which integrin-mediated activation of focal 
adhesion kinase (Fak) activates the MAPK pathway.  Although Fak activation is not well 
understood (Giancotti and Tarone, 2003; Lee and Juliano, 2004), it is known that Fak is 
recruited to focal adhesion complexes and is activated via autophosphorylation on Tyr397, 
thus creating a binding site for the Src homology 2 (SH2) domain of the Src-family 
kinases, Src or Fyn (Giancotti and Ruoslahti, 1999; Giancotti and Tarone, 2003; Lee and 
Juliano, 2004; Schlaepfer et al., 1994).   
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In the first integrin-mediated Fak kinase activation mechanism, Cas and paxillin 
are also recruited to the membrane via integrin-mediated cell adhesion (Hanks and Polte, 
1997).  The combined kinase activity of Fak and the Src-family kinases results in the 
phosphorylation of multiple sites on Fak, Cas, and paxillin (Hanks and Polte, 1997; 
Vuori, 1998).  Phosphorylation of Fak by Src at tyrosine 925 (Tyr925) (Giancotti and 
Ruoslahti, 1999; Lee and Juliano, 2004; Schlaepfer et al., 1994) creates a binding site for 
the Grb2-Sos complex, thereby providing the link between integrin-mediated signaling 
and the canonical MAPK pathway (Giancotti and Ruoslahti, 1999; Lee and Juliano, 2004; 
Renshaw et al., 1999; Schlaepfer et al., 1994; Schwartz and Assoian, 2001).  
  
 In the second integrin-mediated Fak kinase activation pathway, p130Cas interacts 
with Fak through its SH3 domain and is phosphorylated by Src.  This enables recruitment 
of Crk.  Crk associates with either Sos or the guaneonucleotide exchange factor C3G for 
Rap-1, resulting in the activation of B-Raf.  Notably, B-Raf has been linked to Erk 
activation (Barberis et al., 2000), thus providing another pathway linking Fak to MAPK 
activation in cells that express B-Raf  (Giancotti and Tarone, 2003; Lee and Juliano, 
2004).   
 
Another integrin-mediated mechanism that affects MAPK signaling occurs via 
Fak independent activation of the p21-activated kinase (Pak) (Howe et al., 2002).  
Integrin-mediated adhesion relieves the inhibition of protein kinase A (PKA) on Pak 
(Giancotti and Tarone, 2003).  In addition, focal adhesion complexes recruit active Rac, 
which then associates with and activates Pak (Giancotti and Tarone, 2003; Howe et al., 
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2002).  Once active, Pak3 phosphorylates Raf1, while Pak1 phosphorylates Mek1 (Slack-
Davis et al., 2003).  Thus a link between Pak and activation of the MAPK pathway is 
established. 
 
A fifth mechanism by which integrins affect MAPK signaling involves Src-family 
kinases, such as Fyn or Yes (Giancotti and Ruoslahti, 1999; Giancotti and Tarone, 2003).  
Specific α integrin subunits, including α1, α5, αv, bind to the transmembrane adapter 
protein caveolin-1 independently of Fak, through their external and transmembrane 
domains (Giancotti and Tarone, 2003; Lee and Juliano, 2004).  Caveolin-1 links the 
transmembrane portion of the integrin α subunit to the Src-family kinase.  While the 
mechanism by which integrin engagement induces the Src-family kinase activation is not 
well understood, it is known that the activated Src-family kinase undergoes a 
conformational change to expose its Src homology 3 (SH3)-binding domain.  The SH3-
binding domain recruits Shc, which is then phosphorylated at Tyr317.  The Grb2-Sos 
complex then binds to Shc, and ultimately induces Erk activation (Giancotti and Tarone, 
2003; Lee and Juliano, 2004), providing yet another link to MAPK activation.   
 
A sixth pathway by which integrins activate the MAPK pathway involves the Src 
family tyrosine kinase Syk (Miranti et al., 1998).  Prior to activation of Syk, the β3 
integrin subunits are associated with Csk, enabling Csk to phosphorylate the C-terminal 
autoinhibitory site of Src-family kinases; thus all integrin-associated Src-family kinases 
have been rendered inactive (Giancotti and Tarone, 2003).  Upon ECM binding, Csk is 
released from the β3 subunit, enabling activation of integrin-associated Src-family kinases 
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and subsequent recruitment and activation of Syk and ZAP70 (Giancotti and Tarone, 
2003).  Rac exchange factors Vav1 and Vav2 are substrates of Syk/ZAP70 and once 
active, Vav1 recruits Sos, thus providing a link to the MAPK pathway (Reynolds et al., 
2004).   
 
The seventh mechanism by which integrins activate the MAPK pathway is 
through protein kinase C (PKC).  PKC is known to activate Raf, thus providing a link to 
the MAPK pathway (Giancotti and Ruoslahti, 1999, Bjorkoy, 1995 #97).  It has been 
reported that upon phosphatidylcholine (PC) hydrolysis, elevated levels of PC-derived 
1,2 diacylglycerol (DAG) result in PKC-ζ mediated Raf activation (Bjorkoy et al., 1995).  
In addition, phosphoinositide 3 kinase (PI-3K) has been implicated in activating PKCζ, 
which then activates Raf (Giancotti and Ruoslahti, 1999; Mas et al., 2003).  Thus PKC- 
mediated activation of the MAPK pathway through Raf has been reported through two 
distinct pathways. 
 
Importantly, while there are many pathways by which integrins can potentially 
activate the canonical MAPK pathway, not all of these pathways are firmly established 
(Giancotti and Ruoslahti, 1999; Giancotti and Tarone, 2003; Howe et al., 2002; Lee and 
Juliano, 2004; Mas et al., 2003; Miranti et al., 1998).  In addition, these pathways may 
not all exist in every cell line and for every integrin (Giancotti and Tarone, 2003; Miranti 
et al., 1998).  Furthermore, integrin-mediated stimulation has also been shown to activate 
pathways involving Rho (Danen et al., 2000), a GTPase that has been firmly established 
as a cytoskeleton regulator (Ridley and Hall, 1992), and thus provides a possible link 
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between cell morphology and Erk activation.  Additionally, RhoA has been found to 
activate MAP/Erk kinase kinase 1 (MEKK1) in yeast, providing a link between Rho and 
activation of Erk (Chen and Cobb, 2006)  
 
3.2     Deactivation mechanisms 
 
Erk is also concurrently regulated by deactivation machinery.  Deactivation 
pathways can be loosely grouped into one of three motifs.  In the first motif, deactivation 
occurs without stimulus; because this form of deactivation is present in the absence of 
any other stimulation, it is termed as constitutive direct-deactivation.   As the signal 
activation reaction is not an irreversible chemical reaction, an equilibrium reaction exists 
between the active phosphorylated state and the inactive dephosphorylated state.  Thus, 
deactivation due to dephosphorylation of Erk by either dissociation of the active 
phosphorylated signal to an inactive dephosphorylated form due to equilibrium or via 
basal phosphatase activity may occur (Keyse, 2000; Lewis et al., 1998; Tamura et al., 
2002).     
 
In the second motif, active Erk initiates a signaling pathway that ultimately leads 
to transcription of phosphatase(s) that target its deactivation (Brondello et al., 1997; 
Grumont et al., 1996).  Because in this form of deactivation, active Erk essentially targets 
itself, it is referred to as feedback-mediated direct deactivation.    Activation of Erk has 
been observed to regulate map kinase phosphatases (Mkp) through both an upregulation 
of the rate of phosphatase transcription (Brondello et al., 1997) and a reduction in the rate 
of proteosome-mediated degradation (Brondello et al., 1999).  Activation of Erk has been 
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found to induce transcription of Mkp1 and Mkp2 (Brondello et al., 1997).  In addition, 
active Erk has also been observed to upregulate Mkp3 via Erk-mediated binding to its 
regulatory domain (Camps et al., 2000; Camps et al., 1998).  Erk-mediated 
phosphorylation of Mkp1 on Serine-359 and Serine-364 protects it from proteosome-
mediated degradation (Brondello et al., 1999).   In addition, adhesion-mediated regulation 
of phosphatases have also been observed.  For example, the cytoplasmic tail of α1 integrin 
selectively interacts with the ubiquitously expressed T-cell protein tyrosine phosphatase 
(TCPTP) and activates it after adhesion to collagen.  (Mattila et al., 2005).  Several 
addition candidates for Erk-mediated phosphatase upregulation are PAC-1, vaccinia H1-
related (VHR), and haemopoietic protein tyrosine phosphatase (HePTP), all of which are 
known to act on Erk (Keyse, 2000).  
 
In the final deactivation motif, active Erk deactivates one of its upstream 
activators via hyperphosphorylation (Brunet et al., 1994; Buday et al., 1995; Cherniack et 
al., 1995; Dong et al., 1996; Langlois et al., 1995; Wartmann et al., 1997).  This form of 
deactivation is termed feedback-decoupling deactivation.  In the Erk signaling pathway, 
feedback-decoupling deactivation is mediated by both adaptor-targeted feedback (Buday 
et al., 1995; Cherniack et al., 1995; Dong et al., 1996; Langlois et al., 1995) and enzyme-
targeted feedback (Brunet et al., 1994; Wartmann et al., 1997).  In adaptor-targeted 
feedback, Sos complexed with Grb2 undergoes serine/threonine hyperphosphorylation.  
Once hyperphosphorylated, the complex either dissociates from the active receptor 
(Buday et al., 1995) or separates back into Sos and Grb2 (Cherniack et al., 1995; Dong et 
al., 1996; Langlois et al., 1995), both of which render hyperphosphorylated Sos to an 
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inactive state.  Both Erk, and an enzyme downstream of Erk have been implicated as 
responsible for Sos hyperphosphorylation (Anderson et al., 1991; Corbalan-Garcia et al., 
1996).  In enzyme-targeted feedback, Raf (Wartmann et al., 1997), Mek (Brunet et al., 
1994), and Fak (Hunger-Glaser et al., 2003) hyperphosphorylation have been shown to 
trigger signal attenuation.  Consistent with both these findings, hyperphosphorylation of 
Mek on Thr292 and Thr386 (Brunet et al., 1994) and Raf (Brunet et al., 1994; Wartmann et 
al., 1997) on serine residues 29, 43, 289, 296, 301, and 642 have been implicated as 
substrates for Erk (Dougherty et al., 2005).  Hyperphosphorylation of Fak on Serine-910 
is believed to be mediated either via Erk or protein kinase C (Hunger-Glaser et al., 2003).  
Recently, the hyperphosphorylated form of Raf has been observed to return to an active 
signaling state through interaction and dephosphorylation with the serine/threonine  
phosphatase PP2A and the prolyl isomerase Pin1 (Dougherty et al., 2005).  Although 
phosphatases that associate with and activate the inactive hyperphosphorylated forms of 
Mek and Fak via dephosphorylation have not been determined, serine/threonine 
phosphatases that can target many different substrates, such as PP2A, may act to catalyze 
the activation of the inactive hyperphosphorylated forms of Mek and/or Fak.   
 
4. Model Description 
 
4.1     Coarse-grain model 
 
A simple mathematical model which lumps Erk activation and deactivation 
mechanisms into four distinct biological motifs is depicted in Figure IV-2.  In this model, 
the input stimulus (I) activates the signal (S), converting it to its active form (S*) as 
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shown in motif 1, which we term simply as ‘activation.’  The signal S in our model refers 
to Erk.  Active signal (S*) can be deactivated in the absence of any other stimulation as 
illustrated in motif 2, which we term ‘constitutive direct-deactivation.’  Deactivation can 
also occur via feedback mechanisms.  In the first feedback mechanism, active signal (S*) 
deactivates itself as shown in motif 3, which we term ‘feedback-mediated direct-
deactivation.’  In the second feedback mechanism, feedback occurs by converting input 
stimulus (I) to a permanently inactive form (I-) as shown in motif 4, which we term 
‘feedback decoupling deactivation.’   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV-2:  Model schematic 
The input stimulus (I) activates the signal (S), converting it to its active form (S*) as 
shown in motif 1, termed simply as ‘activation.’  Active signal (S*) can be 
deactivated in the absence of any other stimulation as illustrated in motif 2, termed 
‘constitutive direct-deactivation.’  Deactivation can also occur via feedback 
mechanisms.  In the first feedback mechanism, active signal (S*) deactivates itself as 
shown in motif 3, termed ‘feedback-mediated direct-deactivation.’  In the second 
feedback mechanism, feedback occurs by converting input stimulus (I) to a 
permanently inactive form (I-) as shown in motif 4, termed ‘feedback-decoupling 
deactivation.’  In each of these motifs, it is assumed that the kinetics of each 
pathway can be described by a single rate constant.   
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In each of these motifs, it is assumed that the kinetics of each pathway can be 
described by a single rate constant.  Thus, the rate is proportional to the species 
concentration connected by each arrow.  In the decoupling motif, it is assumed that 
permanent deactivation of (I) occurs over the time course of the experiment.  While the 
first assumption may not be valid if non-linear relationships exist between the connected 
species and the second assumption may not be valid at late times, both are reasonable 
starting postulates for a coarse-grain model.   
 
4.2     Activation motif (motif 1) 
 
The activation rate constant kAct incorporates both growth factor- and integrin-
mediated activation pathways when appropriate to the system of study.  Growth factor-
mediated Erk activation contributions to kAct are due to growth factor-induced receptor 
activation that enables formation of Sos-Grb2 (Roovers and Assoian, 2000).  Recall that 
this allows Ras to be activated and initiates a kinase cascade resulting in Erk activation 
(Roovers and Assoian, 2000).  Likewise, adhesion-mediated Erk activation contributions 
to kAct will involve aforementioned integrin mediated pathway(s) leading to subsequent 
Erk activation (Bjorkoy et al., 1995; Giancotti and Ruoslahti, 1999; Hanks and Polte, 
1997; Howe et al., 2002; Mas et al., 2003; Miranti et al., 1998; Schlaepfer et al., 1994; 
Vuori, 1998).  Note that the relative importance of these pathways cannot be determined 
by the model at this stage of development.   
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4.3     Constitutive direct-deactivation (motif 2) 
 
Because constitutive direct-deactivation is independent of feedback control, it is 
written as a reversible step in the model schematic (Figure IV-2).  Contributions from 
constitutive phosphatase activity as well as dissociation of the active phosphorylated 
form of Erk to its inactive dephosphorylated form are incorporated into kconst.  For the Erk 
activation pathway, constitutive phosphatases of importance may include any of the 
aforementioned phosphatases known to act on Erk (Keyse, 2000; Tamura et al., 2002).     
 
4.4     Feedback-mediated direct-deactivation (motif 3) 
 
In feedback-mediated direct-deactivation, the active signal (S*) initiates 
deactivation of itself, thus this deactivation motif is a form of feedback control.  For the 
Erk signaling pathway, direct-deactivation feedback occurs when active Erk initiates a 
signaling pathway that ultimately leads to the transcription of phosphatase(s) that target 
its deactivation (Brondello et al., 1997; Grumont et al., 1996).  All forms of feedback-
mediated direct-deactivation acting on the cell are incorporated into kdir. 
 
4.5     Feedback-decoupling deactivation (motif 4) 
 
Feedback-decoupling deactivation is an activation-targeting form of feedback 
control where the active signal S* acts on the upstream species I and renders it 
permanently inactive by changing it to I-.  As mentioned previously, in the Erk signaling 
pathway feedback-decoupling occurs when active Erk permanently deactivates growth 
factor receptor (Matveev and Smart, 2002), Sos (Buday et al., 1995; Chen et al., 1996; 
Cherniack et al., 1995; Corbalan-Garcia et al., 1996; Langlois et al., 1995), Raf 
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(Wartmann et al., 1997), Mek (Brunet et al., 1994), or Fak (Lee and Juliano, 2004) via 
hyperphosphorylation.  All forms of feedback-decoupling deactivation present in the cell 
are incorporated into kdecoupl. 
 
4.6     Model equations 
 
From the model schematic pictured in (Figure IV-2), differential equations 
describing the signal and input kinetics are shown in Equation 1 below. 
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The following mass balances for signal (S) and input (I) apply (Equation 2):  
 
 
[ ] [ ] [ ]
[ ] [ ] [ ]*
*
III
SSS
o
o
+=
+=
      (Equation 2)  
 
 
Dimensionless parameters are defined as: 
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Substituting the mass balances (Equation 2) and dimensionless parameters (Equation 3)   
into the model equation (Equation 1), the dimensionless form of the model is written: 
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Where the dimensionless groups are defined in Equation 5  
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5. Results and Discussion 
 
 
5.1     Model results 
 
We begin by examining the effect of the activation motif on signaling kinetics in 
the absence and presence of each form of deactivation.  Deactivation motifs are first 
studied separately in order to determine the individual effect of each on temporal profiles.  
Once the contributions of individual motifs are known, we consider the combined effect 
of multiple forms of deactivation on signal dynamics.   
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Figure IV-3: Activation alone induces sustained signal activation.   
The effect varying the activation dimensionless group (κAct) on signaling kinetics.   
 
In the absence of any deactivation mechanism, the rate at which active signal 
(S*), reaches its maximum value is determined by the value of the dimensionless 
activation rate constant, κAct.  As the value of this dimensionless parameter is increased, 
the time taken to achieve maximum intensity decreases (Figure IV-3).  Note that the 
signal intensity is limited between zero and unity due to dimensionalization.   
 
When activation is coupled with only one form of deactivation, a sustained signal 
is observed regardless of the type of deactivation (Figure IV-4).  Although all three 
deactivation dimensionless groups affect signaling kinetics similarly, with signal 
maximum decreasing with increasing dimensionless deactivation constant, each motif 
affects the maximum signal intensity differently (Figure IV-4).  As can be seen from 
Figure IV-4, increasing constitutive direct-deactivation has the greatest impact on signal 
κAct 
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reduction, while increasing feedback decoupling deactivation has the least effect 
(compare Figure IV-4A, to Figure IV-4B, to Figure IV-4C).     
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Figure IV-4: Effect of each form of deactivation on signal activation kinetics.  
 The effect of activation and only one form of deactivation was investigated.  
Dimensionless groups for (A) constitutive direct-deactivation (κconst), (B) feedback-
mediated direct-deactivation (κdir), and (C) feedback-decoupling deactivation (κdecoupl) 
were varied to determine the effect of each on signaling kinetics.     
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When activation and all three forms of deactivation are present, a transient signal 
is observed (Figure IV-5).    Because no transient activation is observed in the presence 
of a single deactivation motif (Figure IV-4), a transient signal requires multiple forms of 
deactivation.  Furthermore, we find that all three motifs of deactivation are not necessary 
to obtain a transient signal.  Our model demonstrates that the minimal requirement for 
transient signaling is that feedback decoupling deactivation must be complemented by at 
least one form of direct-deactivation (Figure IV-6, compare A to B and C).   
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Figure IV-5: Activation and all three forms of deactivation results in transient 
signal activation.   
A transient signal is observed when activation and all three forms of deactivation are 
present.   
 
 
Analysis of Figure IV-5 and Figure IV-6 illustrates that activation, feedback- 
decoupling deactivation, and one form of direct-deactivation are required for 
establishment of a transient signal.  Therefore, we begin our detailed analysis of transient 
signaling kinetics by investigating the importance of the magnitude of activation on the 
observed transient profile.  Following this analysis, the effects of deactivation are 
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Figure IV-6: Feedback-decoupling deactivation and one form of direct-deactivation is 
required for transient signal attainment  
(A) Both forms of direct deactivation (constitutive and feedback-mediated) result in 
sustained signal kinetics.  Feedback decoupling deactivation plus either (B) constitutive or 
(C) feedback-mediated direct deactivation result in transient signal kinetics.   
 
investigated, starting with feedback decoupling.  Recall that in addition to feedback-
decoupling deactivation, one form of direct-deactivation is also required for attainment of 
a transient signal.  Thus, two distinct cases are investigated that include activation and 
feedback-decoupling deactivation either with (1) constitutive direct-deactivation as the 
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required form of direct-deactivation, or (2) feedback-mediated direct-deactivation as the 
necessary form of direct-deactivation.  To facilitate comparison between each of these 
cases across analyses, a common profile with κact = 5, κdecoupl = 1 and κdirect_deactivation = 1 
(where the form of direct deactivation is either constitutive or feedback-mediated) is 
provided for reference in each of the graphs presented, and this common profile always 
appears as a solid line.  Thus, the relative effect of varying each motif independently can 
be determined by comparing the reference (solid line) provided for each case.  Note that 
the reference is not equivalent across cases as the common profiles are not equivalent 
when different forms of direct deactivation are present.   
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Figure IV-7: The effect of varying activation on transient profiles 
Varying activation results in an increase in peak signal magnitude regardless of whether 
the required form of direct-deactivation is due to (A) constitutive or (B) feedback-mediated 
direct-deactivation  
 
We find that identical trends are observed in the resultant transient profile when 
activation is varied regardless of which form of direct-deactivation is present.  In either 
case, increasing the magnitude of the activation dimensionless group increases the 
κAct  κAct 
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maximum peak intensity and the time at which signal returns to basal is not affected 
(Figure IV-7A).     
 
As feedback-decoupling is the only form of deactivation that is required for 
establishment of a transient signal, we begin our analysis of the effect of deactivation on 
transient signaling kinetics by investigating the importance of the magnitude of feedback-
decoupling deactivation on the observed transient signaling profile.  Again, two distinct 
cases are investigated: activation and feedback-decoupling deactivation in the presence of 
either constitutive (Figure IV-8A) or feedback-mediated (Figure IV-8B) direct-
deactivation.   
 
A 
0 2 4 6 8 10
0
0.2
0.4
0.6
0.8
1
time
S
/S
*
κAct = 5      κConst = 1      κDir = 0
 
 
κDecoupl = 5
κDecoupl = 3
κDecoupl = 1
B 
0 2 4 6 8 10
0
0.2
0.4
0.6
0.8
1
time
S
/S
*
κAct = 5      κDir = 1      κConst = 0
 
 
κDecoupl = 5
κDecoupl = 3
κDecoupl = 1
 
Figure IV-8: The effect of varying feedback-decoupling deactivation on transient 
profiles  
 Varying decoupling deactivation results in depression of the maximum signal intensity 
and acceleration of the signal return to basal regardless of whether the required form of 
direct-deactivation is due to (A) constitutive or (B) feedback-mediated direct-deactivation.  
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We again find that the observed trends are the same, regardless of which form of direct-
deactivation is present.  When the feedback-decoupling deactivation dimensionless group 
is increased, peak signal intensity is depressed and the return to basal levels is accelerated 
(Figure IV-8).  
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Figure IV-9: The effect of varying direct-deactivation on transient profiles   
Increasing the direct-deactivation dimensionless group results in peak signal magnitude 
depression without affecting the signal’s return to basal signal level regardless of whether the 
required second form of direct- deactivation is due to (A) constitutive or (B) feedback-mediated 
direct-deactivation.  
 
 
In order to more fully understand how the direct-deactivation motifs affect 
signaling kinetics, the dimensionless group for either constitutive or feedback-mediated 
direct-deactivation was varied independently in the presence of the other two required 
motifs: activation and feedback-decoupling deactivation.  Increasing either form of 
κDir 
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direct- deactivation results in depressing the signal peak intensity without affecting the 
signal’s return to basal level (Figure IV-9).    
 
Our model reveals that feedback-decoupling deactivation and one form of direct-
deactivation are both necessary and sufficient for establishment of a transient signal 
(Figure IV-6).  Observed trends for activation and feedback-decoupling are similar 
regardless of which form of direct-deactivation (constitutive or feedback) is present.  
Furthermore, when the magnitude of the activation dimensionless group is increased, our 
model predicts that an increase in signal peak magnitude will occur without affecting the 
time at which signal returns to basal (Figure IV-7A).  In contrast, when the feedback 
decoupling deactivation dimensionless group is increased, peak signal intensity is 
depressed and the return to basal levels is accelerated.  In addition, we find that 
increasing direct-deactivation (either constitutive or feedback-mediated) results in 
depressing the signal peak intensity without affecting the signal’s return to basal levels.   
Finally, our model indicates that the constitutive form direct-deactivation has a greater 
impact on signal kinetics than does feedback-mediated direct-deactivation, regardless of 
which parameter is being varied.  
5.2     Comparison to experimental results 
 
 
We use the results of the model to focus the search for potential mechanisms 
responsible for experimentally observed Erk activation profiles.  The model is first used 
to focus the search for molecular mechanisms responsible for the observed adhesion-
induced enhancement EGF-mediated Erk signaling.  The model is then later used to 
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investigate potential mechanistic explanations for the observed differences in signaling 
kinetics in adherent cells stimulated by each of the three growth factors (EGF, PDGF, or 
bFGF).  
   
 
A 
 
B 
 
C  
Figure IV-10: Experimental Erk activation profiles 
A single asterisk denotes that Erk activation in the adherent and suspended profiles is 
statistically equivalent, while a double asterisk denotes the two profiles are statistically 
different using Student’s t-test.  (A) EGF-mediated Erk activation is transient for both 
adherent and suspended cells.    Cells were stimulated with 800 pM EGF for the indicated 
times.  (B) PDGF induces transient Erk activation in adherent cells.  Cells were stimulated 
with 800 pM PDGF for the indicated times.  (C) bFGF induces sustained activation of 
Erk. Cells were stimulated with 1000 pM bFGF for the indicated times prior to lysing.  
The graph represents a single experiment.  
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The results of our experiments demonstrate that EGF clearly induces a transient 
activation of Erk in both adherent and suspended cells.  In both cases, the signal returns 
to basal within one hour following stimulation (Figure IV-10A).  Classification of PDGF-
mediated Erk activation in adherent cells requires use of our definitions for transient and 
sustained.  Note that PDGF-mediated Erk activation in adherent cells peaks and steadily 
decreases to one-third of the maximal signal intensity.  Therefore, according to our 
definition that a sustained signal peaks and maintains a signal that is equal to at least half-
maximum, PDGF-stimulation also induces a transient activation of Erk (Figure IV-10B).  
In contrast, bFGF-mediated Erk activation in adherent cells is indubitably sustained 
(Figure IV-10C) as the signal remains at maximum signal intensity throughout the time 
course. 
  
The model is first used to narrow down potential mechanism(s) responsible for 
the observed enhancement of EGF-mediated Erk activation in adherent cells as compared 
to suspended cells.  Note that for adherent and suspended cells stimulated via EGF, the 
early phase of Erk activation (< 1 h) is adhesion-dependent, while the late phase of the 
signal reaches a nearly equivalent, basal signal for both adhered and suspended cells 
(Figure IV-10A).  In addition, both the adherent and suspended cells reach maximum 
signal intensity rapidly (Figure IV-10A).  One possible explanation is that the magnitude 
of the activation dimensionless group is greater in the adherent cells than in the 
suspended cells (Figure IV-7).  As adhesion is known to induce Erk activation by 
mechanisms distinct from growth factors, an increase in the activation dimensionless 
group for cells adhered to fibronectin is a likely explanation.  However, the model also 
reveals that differences in either of the two required forms of deactivation required for 
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transient signal attainment could be responsible for the observed difference in signal peak 
magnitude (Figure IV-8 and Figure IV-9).  As the possibility that adhesion reduces 
negative feedback cannot be discounted, both differences in activation and deactivation 
mechanisms may occur.  
 
 
The model is then used to predict potential mechanisms explaining dynamic 
differences resulting from differential growth factor stimulation.  As the model incidated 
that only the presence of feedback-decoupling deactivation and one form of direct-
deactivation result in transient profile attainment (Figure IV-5; Figure IV-6, A-C), these 
motifs must be present in both EGF- or PDGF-mediated stimulation of adherent cells 
(Figure IV-6, A-C).  In addition, the model predicts that for bFGF simulation of adherent 
cells, either no deactivation (Figure IV-3), any single form of deactivation (Figure IV-4), 
or both forms of direct-deactivation (Figure IV-6A) may be responsible for the observed 
sustained kinetic profile.  
 
6. Conclusions 
 
A simple coarse-grain mathematical model was developed to focus the search for 
molecular mechanism(s) driving the magnitude and kinetics of experimentally observed 
Erk activation profiles.  However, it should be noted that the model is not restricted to 
investigation of Erk activation, but rather, can be applied to any system in which the four 
identified motifs are present.  The model demonstrates that activation, feedback-
decoupling deactivation, and one form of direct-deactivation are required to generate a 
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transient signal.  Interestingly, the form of direct-deactivation (either constitutive or 
feedback-mediated) has no effect on the observed signaling trend.   We also find that 
increasing the magnitude of the activation dimensionless group increases the maximum 
signal peak and the time at which signal returns to basal is not affected, regardless of 
which form of direct-deactivation is present.  Notably, the activation dimensionless group 
has the most significant affect on peak signal magnitude.  In contrast, when the feedback-
decoupling deactivation dimensionless group is increased, peak signal intensity is 
depressed and the return to basal levels is accelerated irrespective of which form of 
direct-deactivation is present.  Lastly, we find that increasing either required form of 
direct-deactivation (constitutive or feedback-mediated) results in signal peak intensity 
depression without affecting the signal’s return to basal level.  Interestingly, in all cases, 
the signaling kinetics are most sensitive to variation of any single motif’s dimensionless 
group when constitutive direct-deactivation is the required form of direct-deactivation, 
instead of feedback-mediated direct-deactivation being present.   
 
Our model results are used to narrow the search for the molecular mechanisms 
responsible for our experimental observations detailed in Chapter 3.   Recall that our 
experimental results demonstrate that EGF-stimulation clearly induces transient Erk 
activation in both adherent and suspended cells, and that this EGF-mediated Erk 
activation is adhesion-dependent.  Furthermore, a comparison of adherent and suspended 
experimental activation profiles reveals that adherent and suspended cells exhibit similar 
signaling dynamics, but differ in maximum peak intensity with signal magnitude being 
enhanced in adherent cells.  Thus, our model suggests the most likely mechanism 
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responsible for adhesion-dependent Erk activation is an increase in the activation rate 
constant upon adhesion.  Alternatively, the model also indicates decreasing any 
deactivation dimensionless group can enhance signal magnitude, but not to nearly as 
great as an extent as that resulting from an increased activation rate.   
  
Model results can also be used to focus the mechanistic search for the intriguing 
differences in Erk activation dynamics resulting from stimulation of adherent cells by 
distinct growth factors.  Recall that the model predicts that decoupling deactivation must 
be present in cells stimulated by either PDGF or EGF due to the generation of a transient 
Erk activation signal.  If we discover decoupling deactivation occurs in bFGF-stimulated 
adherent cells, the model predicts direct-deactivation cannot be present in these cells and 
still produce sustained Erk activation.  Thus, in this case, the presence of direct- 
deactivation in PDGF- and EGF-stimulated adherent cells, and its absence in bFGF-
stimulated adherent cells, would be the mechanism responsible for differences in Erk 
activation dynamics.  However, if no feedback-decoupling deactivation is found to occur 
in adherent cells stimulated by bFGF, the model predicts that any form(s) of direct- 
deactivation result in the observed sustained Erk activation.  Thus, in this case it would 
be the presence of feedback-decoupling in PDGF- and EGF-stimulated adherent cells, 
and its absence in bFGF-stimulated adherent cells, that would be the mechanism 
responsible for the observed differences in Erk activation dynamics.   
 
We use the results of this simple coarse-grain mathematical model to elucidate 
how specific molecular mechanisms contribute to the dynamics of Erk signaling.   Model 
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results are then compared to our experimentally determined Erk signaling profiles 
(Chapter 3) to infer potential mechanisms and to direct future experiments. To that end, 
both the significance of our findings and the future work suggested by our experiment 
results (Chapter 3) and model predictions (Chapter 4) will be discussed in detail in 
Chapter 5.  
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Chapter V.   Conclusions and Future Work 
 
1. Significance of Findings  
 
This study demonstrates that cell adhesion has quantitatively intricate effects on 
growth factor-mediated Erk signaling.  We reported that the effect of cell adhesion is 
specific to the type of growth factor, its dose, and the timing of stimulation.  Our system 
utilizes a single cell line, and each study is subjected to identical experimental conditions 
prior to growth factor stimulation to ensure that valid comparisons and conclusions are 
drawn.  We find that adhesion to FN selectively enhances Erk signaling elicited by EGF, 
but has no effect on bFGF- or PDGF-mediated Erk activation.  Unexpectedly, at 
concentrations of PDGF and bFGF that are significantly less than the dissociation 
constant, cell adhesion severely attenuates growth factor-mediated Erk signaling.  Thus, 
adhesion not only enhances cell response to specific growth factors, but also filters out 
potentially noisy signals from low levels of growth factor.   
 
Our study reveals that cell adhesion is not always a positive effector of signal 
transduction and that, surprisingly, cell adhesion can negatively affect signaling.  Thus, 
cell adhesion can no longer be viewed exclusively as a positive activator of signaling.  
Instead, we must adjust our view of adhesion; adhesion can act as either a positive or 
negative regulator of activation.  Importantly, this change in perspective will be 
significant in the area of biomaterial development as researchers must now consider the 
possibility that enhancing adhesivity could inadvertently quiesce the very signals they are 
trying to augment.  Such considerations will be especially important in selecting adhesive 
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epitopes to integrate into biomaterial surfaces.  The potential for adhesion to negatively 
regulate signal activation also suggests researchers will need to develop assays to 
ascertain whether or not they have accidentally incorporated this negative effect into the 
biomaterial surface under development.  To that end, our findings raise the question of 
whether we can decouple the mechanisms of adhesion-mediated negative and positive 
regulation on signal activation so that biomaterial surfaces can be developed which 
incorporate only the desirable positive effects of adhesion on signal activation.  
 
In addition, our study begins to provide a systematic comparison of the crosstalk 
between adhesion and three different growth factors.  Deciphering these and other 
quantitatively intricate ways in which cell adhesion influences growth factor signaling 
will be crucial to developing a better understanding of how the adhesive 
microenvironment ‘primes’ cell behaviors.  Such quantitative insight will be important in 
designing synthetic microenvironments for applications such as tissue engineering and 
regenerative medicine, where rigorous quantification will be required.   In addition, 
quantification will enable improved assessment of the quality and effectiveness of both 
biomaterials and cancer therapies. 
 
 
2. Overview of Future Research 
 
Future work will focus on uncovering the molecular mechanisms governing the 
three most significant experimental results: (1) adhesion-mediated desensitization of 
signal activation by selective growth factors, (2) adhesion-dependent Erk activation 
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enhancement by EGF stimulation, and (3) growth-factor specific signaling dynamics of 
Erk activation in adherent cells.  Investigation into potential pathways contributing to the 
observed Erk signaling kinetics may have a bilateral approach; either experimental data 
independently or experimental data in combination with model predictions may be used 
to guide future experiments.  Experimental results may be used to design additional new 
experiments to ascertain which upstream activator is responsible for adhesion-dependent 
growth factor-mediated desensitization of Erk activation.   In contrast, experimental data 
in conjunction with model results may be used to focus the mechanistic search for both 
EGF-mediated adhesion-dependent Erk activation and growth-factor specific Erk 
signaling dynamics in adherent cells.   
 
 
3. Adhesion-Mediated Desensitization of Signal Activation by Selective Growth 
Factors 
 
3.1     Background 
 
Our experimental work discussed in detail in Chapter 3 demonstrates that at 
critical sub-saturating doses of PDGF or bFGF, adhesion to fibronectin actually 
desensitizes the cell to growth factor stimulation, rendering the signaling pathway 
unresponsive to growth factor.  Our experimental findings are particularly interesting 
given that adhesion is historically considered as a positive effector.  However, while 
adhesion-mediated desensitization is a novel finding, there are many examples of Erk 
signaling desensitization in the literature, where exposure to a growth factor desensitizes 
the cell from signal activation when exposed to a second charge of the same and/or 
different growth factor.   
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As the hyperphosphorylation of Sos in response to growth factor stimulation has 
been found to be a prominent mechanism by which growth factor desensitizes Erk 
signaling (Chen et al., 1996; Cherniack et al., 1995; Corbalan-Garcia et al., 1996; 
Langlois et al., 1995), we began our search for the mechanism of adhesion-mediated 
desensitization of Erk activation to EGF/PDGF-stimulation by assaying Sos 
hyperphosphorylation.  However, experimental results clearly demonstrate that adhesion 
to FN does not induce Sos hyperphosphorylation in our system (Figure III-6, III-16).  
Thus, the adhesion-mediated desensitization we observe does not occur at the level of Sos 
regulation.   
 
To focus our search for the mechanism responsible for adhesion-induced 
desensitization, we varied the ‘priming time,’ or duration of adhesion prior to growth 
factor stimulation, and found that priming time was critical to the desensitization process.  
Interestingly, Erk and Akt activation significantly improved only when pre-exposure to 
adhesion was completely eliminated and concurrent stimulation of adhesion and growth 
factors occurred.  However, concurrent stimulation by growth factor and adhesion was 
only able to partially rescue adhesion-mediated desensitization of PDGF- and bFGF-
mediated Erk and Akt signaling.  The fact that concurrent stimulation was not able to 
fully rescue adhesion-mediated desensitization to PDGF or bFGF suggests that the time 
scale of desensitization is rapid.  Moreover, because both Ras and growth factor receptors 
are known to be upstream activators of Akt (Downward, 2004; Shaw and Cantley, 2006), 
these findings further suggest that adhesion-mediated desensitization targets a regulatory 
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point upstream of Ras and proximal to growth factor receptor activation.  Thus, although 
Sos is not the target of desensitization, another signal proximal to growth factor detection 
must be involved.   
 
In fact, several growth factor receptors directly interact with adhesion receptors 
(Comoglio et al., 2003).  While the association of growth factor receptors with adhesion 
receptors has been predominantly correlated with positive synergism, it may also 
sequester and inhibit the activity of low levels of ligand-bound growth factor receptors.  
Indeed, such heterologous desensitization by receptor sequestration has been 
demonstrated for EGFR and PDGFR via stimulation by PDGF or EGF (Matveev and 
Smart, 2002).  Hence, there is precedent for desensitization to selectively affect a subset 
of growth factors (Hupfeld et al., 2005; Matveev and Smart, 2002). 
 
3.2     Future work 
 
To test if regulation occurs at the level of growth factor receptor, phosphor-
tyrosine blots may be run for both adherent and suspended cells stimulated with either 
PDGF or bFGF using the experimental system we developed.  If differences in growth 
factor receptor tyrosine phosphorylation levels are observed over the time course, this 
indicates that some form of regulation occurs at the level of growth factor receptor.  To 
investigate this mechanism further, development of an adhesion-mediated receptor 
sequestration assay, possibly adapting the solid-phase binding assay protocol outlined by 
Wijelath and colleagues (Wijelath et al., 2002), would be required.   If growth factor 
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receptor sequestration levels cannot explain regulation at the level of receptor, alternate 
mechanisms would have to be investigated to explain the observed result.    
 
One such possible mechanism may involve direct interactions between growth 
factors and ECM proteins.  Sequestration of TGFβ, VEGF, and HGF by ECM is well 
documented (Griffith and Swartz, 2006).  In fact, VEGF has recently been shown to bind 
specific sites on FN, suggesting potential sequestration in more basic reconstituted 
systems.   Thus, ECM protein-mediated sequestration may play a role in diminishing 
PDGF- or bFGF-mediated signaling on FN-coated dishes, especially in systems 
employing low doses of growth factor (Wijelath et al., 2006).  In order to determine if 
PDGF and bFGF binding to FN is responsible for the observed adhesion-mediated 
desensitization, we would need to develop an assay to determine if binding to FN is 
depleting our stimulation medium of growth factor.  If PDGF- and bFGF-depletion via 
binding to FN is found to occur, depletion of EGF via binding to FN would be tested to 
determine if a lack of binding explains why no adhesion-mediated desensitization is 
observed for stimulation via EGF.  
 
Finally, if regulation does not occur at the level of growth factor receptor, we will 
investigate regulation at the level of Ras.  In order to determine if Ras activation is the 
mechanism responsible for the observed adhesion-mediated desensitization to 
bFGF/PDGF, but not EGF, the levels of active Ras in PDGF- and bFGF-stimulated 
adherent cells could be compared to those of suspended cells.  Substantial depression of 
  
V-7
Ras activation in adherent cells as compared to suspended cells will indicate that 
desensitization likely occurs at the level of Ras.  
 
4. Adhesion-Dependent Erk Activation Enhancement by EGF Stimulation 
 
4.1     Background 
 
A simple coarse-grain mathematical model was developed to focus the search for 
molecular mechanism(s) driving the magnitude and kinetics of experimentally observed 
Erk activation profiles.  The model demonstrated that while activation, feedback-
decoupling deactivation, and one form of direct-deactivation (either constitutive or 
feedback-mediated) is required for transient signal attainment, a sustained signal is 
generated provided that feedback-decoupling deactivation never occurs in the presence of 
any other form of deactivation.  Thus, a sustained signaling profile occurs in the presence 
of activation and (1) no deactivation, (2) a single form of deactivation, or (3) both forms 
of direct-deactivation.       
 
For transient activation profiles we find that: (1) increasing the magnitude of the 
activation dimensionless group increases the maximum peak, but that the time at which 
the signal returns to basal levels is not affected, (2) increasing the decoupling- 
deactivation dimensionless group depresses peak signal intensity and accelerates the 
signal’s return to basal levels,  (3) increasing either constitutive direct deactivation or 
feedback-mediated direct-deactivation results signal depression without affecting the time 
at which the signal returns to basal levels, and (4) the presence of constitutive direct 
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deactivation in place of feedback-mediated deactivation has a greater affect on signaling 
kinetics.  
 For sustained activation profiles, we find that the signal reaches a maximum and 
is maintained at maximum for the entire length of the time course.  We also observe that 
increasing the magnitude of the activation group increases the maximum signal, while 
increasing the magnitude of any deactivation dimensionless group decreases the 
maximum signal.   
 
4.2     Future work 
 
Focusing first on the mechanism(s) responsible for the presence of adhesion-
dependent enhancement of Erk activation signal intensity in cells stimulated via EGF, we 
note both adherent and suspended cells induce transient activation of Erk.  Thus, although 
according to our model, activation, feedback-decoupling deactivation, and one form of 
direct deactivation (either constitutive or feedback-mediated) must occur to obtain a 
transient profile, the important difference in adhesion-dependent Erk activation induced 
via EGF stimulation is that the peak signal magnitude differs between adherent and 
suspended cells.  Therefore, we look to model predictions to determine which 
dimensionless group affects the magnitude of signal peak intensity.  Our model predicts 
the enhancement in signal peak magnitude may occur by either an increase in the 
activation rate constant (κAct) or an decrease in a deactivation rate constant (κConst, κDir, or 
κDecoupl).  Notably, our model demonstrates that variation in the activation rate constant 
has the greatest affect on signal peak magnitude    
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In addition, adhesion-mediated signal enhancement is reported for a wide number 
of signaling proteins including Fak (Guilherme et al., 1998), Ras (DeMali et al., 1999),  
Raf (Lin et al., 1997), and Mek (Renshaw et al., 1997) activation.  Thus, an increase in 
κAct is the most likely explanation for the observed phenomena.  Note that because the 
relative importance of activation pathways cannot be determined by the model at this 
stage of development, all known forms of activation must be considered.    In order to 
focus the mechanistic search, we will begin our investigation of activation pathways by 
determining the Akt activation profile for adherent and suspended cells.  Because Akt is 
activated by both Ras and growth factor receptors, equivalent Akt activation levels in 
adherent and suspended cells indicate that regulation of adhesion-induced enhancement 
of Erk affects the MAPK signaling pathway below the level of Ras activation.  In 
contrast, adhesion-dependent Akt activation suggests regulation occurs at or above the 
level of Ras activation.  Knowledge of whether adhesion-induced enhancement occurs (1) 
downstream of Ras activation or (2) at or upstream of Ras activation will elucidate which 
integrin-activation pathways should be more thoroughly investigated.   
 
However, when investigating these activation pathways as possible mechanisms, 
it is important not to overlook differences in the deactivation dimensionless group(s) in 
adherent and suspended cells as potential points of regulation for adhesion-dependent Erk 
activation.  Because enhancement of deactivation pathways has never been reported to 
contribute to adhesion-dependent signal enhancement, possible contributions from 
feedback-decoupling deactivation and/or direct deactivation will only be investigated if 
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no enhancement of activation pathway(s) are determined to be of mechanistic importance 
to adhesion-mediated enhanced of Erk signaling.   
 
5. Growth-Factor Specific Signaling Dynamics of Erk Activation in Adherent Cells 
 
5.1     Background   
 
We focus now on the mechanism responsible for growth factor specific Erk 
signaling dynamics.  Our experiments revealed that while adherent cells stimulated by 
either EGF or PDGF generate transient Erk activation, adherent cells stimulated via 
bFGF produce sustained Erk activation.  According to our model, activation, feedback 
decoupling, and at least one form of direct deactivation (either constitutive or feedback-
mediated) are necessary for the transient activation of Erk observed for adherent cells 
stimulated via EGF or PDGF.   In contrast, our model predicts that either feedback 
decoupling alone or any form(s) of direct deactivation are necessary for the sustained Erk 
activation profile observed in cells stimulated via bFGF.   
 
5.2     Future work 
 
 
Recall that feedback-decoupling deactivation is known to occur in cells stimulated 
via PDGF (Figure III-6, page III-16).  As one of our model assumptions is that feedback 
decoupling is irreversible, this finding gives us the opportunity to validate our model 
assumptions via assaying temporal Sos hyperphosphorylation profiles in adherent cells 
stimulated via PDGF.  Importantly, if hyperphosphorylated proteins are found to return to 
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their active unphosphorylated state over the time-course of the experiment, the 
assumption of irreversible feedback would have to be revised.  Current modeling 
equations would then be modified to include reversibility of feedback-decoupling 
deactivation and the resulting predictions from the modified model would be used to 
further guide our search.  However, if our assay reveals that decoupling feedback renders 
proteins permanently inactive, maintaining them in the hyperphosphorylated form 
throughout the duration of the experiment, our assumption of irreversible feedback 
decoupling is valid.  Current modeling predictions can be used in the continued search for 
the molecular mechanism responsible for differences in Erk signaling dynamic by 
different growth factors.   
 
To search for the molecular mechanism responsible for PDGF-mediated 
stimulation inducing transient Erk activation, while bFGF-mediated stimulation induces a 
sustained Erk activation, we will investigate if the presence of decoupling-feedback due 
to PDGF treatment is the point of regulation.  We will determine whether feedback-
decoupling deactivation occurs via bFGF-mediated stimulation by assaying for protein 
hyperphosphorylation of Sos, Raf, Mek, and Fak, using techniques described previously.  
To assay if decoupling deactivation due to adhesion-mediated receptor sequestration or 
ECM protein sequestration of growth factor ligands are responsible, further investigation 
and development of assays to ascertain the presence of these forms of decoupling 
deactivation must occur.  
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If feedback-decoupling deactivation is not found to occur due to bFGF-
stimulation of adherent cells, feedback-decoupling deactivation in cells stimulated via 
PDGF, and not in cells stimulated via bFGF, would be the mechanism responsible for the 
observed transient Erk activation resulting from  PDGF-stimulation and sustained Erk 
activation produced by bFGF-stimulation.  
 
In contrast, if feedback-decoupling deactivation is found to occur in cells 
stimulated by bFGF, the model indicates that direct-deactivation should be investigated 
as point of regulation in Erk signaling kinetics.  The presence of direct deactivation in 
cells stimulated by PDGF, but not bFGF, would explain the observation that a transient 
signal is obtained for PDGF-stimulated cells, while a sustained signal for is obtained in 
bFGF-stimulated cells.  The most comprehensive method to test for direct deactivation is 
to develop a phosphatase assay that uses a kinase inactive form of Erk as a substrate.  
Phosphatase activity measured by this assay prior to growth factor-stimulation would 
indicate the presence of constitutive direct-deactivation, while an increase in phosphatase 
activity in growth factor-stimulated cells would indicate that feedback-mediated direct-
deactivation is present.  However, as development of such an assay is an intensive 
process, Western blotting against phosphatases known to act on Erk (such as Mkp1 and 
Mkp4) is a suitable alternative method to assay for the presence of direct-deactivation.  
The presence of phosphatases via Western blotting before growth factor stimulation 
would again indicate the presence of constitutive direct-deactivation, while the 
upregulation of phosphatases levels after growth factor-stimulation would reveal the 
presence of feedback-mediated direct deactivation.  If Western blotting reveals either the 
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presence of constitutive or feedback-mediated direct-deactivation, further development of 
the phosphatase assay will be unnecessary, as direct deactivation would be revealed as 
the mechanism responsible for PDGF-mediated transient Erk activation and bFGF-
mediated sustained Erk activation.  
 
Determination of the mechanism responsible for the dynamic differences in cells 
stimulated via EGF, compared to those stimulated via bFGF will be identical to the 
process outlined above for PDGF.  The only difference is that the form of feedback-
decoupling deactivation that occurs in cells stimulated via EGF must be determined 
following the methodology outlined previously to determine the source of feedback-
decoupling deactivation that occurs in adherent cells stimulated by EGF. 
 
6. Conclusions 
 
Our experimental findings (Chapter 3) have begun to elucidate quantitative 
aspects of the crosstalk between adhesion and individual growth factors.  We have laid 
out a process for elucidating the precise mechanisms responsible for: 1) adhesion-
mediated desensitization of signal activation by selective growth factors, 2) adhesion-
dependent Erk activation enhancement by EGF stimulation, and 3) growth factor-specific 
signaling dynamics of Erk activation in adherent cells.  Many of the proposed 
experiments are guided by model predictions that identify key mechanisms required to 
elicit specific aspects of Erk signaling dynamics.  Pursuing the proposed experiments will 
yield mechanistic understanding of the quantitatively intricate ways in which cell 
adhesion influences growth factor signaling.  This understanding will offer insights into 
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how the adhesive microenvironment ‘primes’ cell behaviors such as survival, apoptosis, 
proliferation, and migration.  Such quantitative insight will enhance our ability to both 
design synthetic microenvironments for applications such as tissue engineering and 
regenerative medicine.  In addition, quantification will enable improved assessment of 
the quality and effectiveness of both biomaterials and cancer therapies. 
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Chapter VI. Appendices 
 
 
 
Supplemental Figure VI-1: bFGF does not induce Erk signaling in an adhesion-
dependent manner for any portion of the time course.  
NIH-3T3 cells were prepared as described in the legend to Figure III-1.  Cells that were either 
maintained in suspension on PH (empty circles) or allowed to adhere on FN (filled squares) for 
2.5 hr were stimulated with 1000 pM bFGF for the indicated times prior to lysing.  The relative 
amount of active Erk (ppErk) normalized to the equal-loading control, total Erk (ErkT), is 
reported for the different treatment conditions. The graph represents a single experiment.  
 
 
 
Supplemental Figure VI-2: At the critical bFGF concentration of 1 pM, suspended cells 
strongly induce Erk activation, while Erk activation remains near basal in adherent cells.   
NIH-3T3 cells were prepared as described in the legend to Figure III-1.  After being maintained 
in suspension by PH (empty circles) or allowed to adhere on FN (filled squares) for 2.5 hr, cells 
were stimulated with the critical concentration of 1 pM bFGF.  The relative amount of active 
Erk (ppErk) normalized to the equal-loading control, total Erk (ErkT), is reported for the 
different treatment conditions.  The graph represents one to three independent experiments, with 
n > 1 for the 0 and 30’ time point.  The double asterisk denotes that 1 pm bFGF-mediated ERK 
activation in suspended and adherent cells is statistically different (P < 0.01). 
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Supplemental Figure VI-3: At the critical bFGF concentration of 1 pM bFGF, 
suspended cells also strongly induce Akt activation, while Akt activation remains 
near basal in adherent cells.   
NIH-3T3 cells were prepared and analyzed identically to those in Figure III-1. Total cell 
lysates were assayed by immunoblot analysis using antibodies specific to total Erk 
(ErkT) and phosphorylated Akt (pAkt).  The relative amount of active Akt (pAkt) 
normalized to the equal-loading control, total cellular Erk (ErkT), is reported for the 
different treatment conditions.  The graph represents a single experiment. 
 
 
 
